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7-AAD – 7-aminoactinomycin D 
Abs – antibodies 
AITD – autoimmune thyroiditis 
APC – allophycocyanin 
ARS – at-risk subjects 
BMI – body mass index 
CD – Crohn’s disease 
CRP – C-reactive protein 
EBV – Epstein-Barr virus 
ELISA – enzyme‐linked immunosorbent assay 
GWAS – genome wide association study 
HCs – healthy controls 
HERV – human endogenous retrovirus 
HLA – human leucocyte antigen 
HP – Helicobacter pylori 
HT – Hashimoto’s thyroiditis 
IL – interleukin 
INFγ – interferon gamma 
L5P – lipopentapeptide 
LADA – latent autoimmune diabetes of adults 
LPS – lipopolysaccharide 
MAP – Mycobacterium avium subsp. paratuberculosis 
MAS – multiple autoimmune syndrome 
MS – multiple sclerosis 
NOD – non-obese diabetic (mouse) 
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TGFβ – transforming growth factor beta 
TNFα – tumor necrosis factor alpha 
TPO – thyroperoxidase 
UC – ulcerative colitis 
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Although numerous studies put in evidence the increasing incidence of type 1 diabetes (T1D), 
its cause remains unclear. The role of Mycobacterium avium subsp. paratuberculosis (MAP) as a 
putative environmental agent triggering or accelerating the disease has been previously 
hypothesized in Sardinian and Italian T1D populations. The present thesis further sustains this 
association by reporting an elevated seroreactivity to MAP-derived epitopes and homologous human 
peptides corresponding to proinsulin and ZnT8 fragments in populations at different T1D stages and 
originating from distinct biogeographic backgrounds. Anti-MAP antibodies (Abs) resulted detectable 
in the first months of life before the appearance of classical autoantigens and, in most cases, were 
maintained in time making the selected peptides good candidates for early biomarkers. Likewise, 
Abs responses to the same antigens were observed among LADA patients and subjects affected by 
Hashimoto’s thyroiditis which frequently complicates T1D. Validation with a MAP-specific 
lipopentapeptide confirmed these results in coincidence with a stable Abs status. In PBMC primary 
culture, ZnT8 peptide and its MAP homolog induced the expression of proinflammatory cytokines 
along with increased cell-mediated responses and apoptosis. Good correlation between values 
obtained for the homologous MAP/human peptide pairs point at cross-reactivity through which 

















Magdalena Niegowska Conforti  – Immunogenicity of Mycobacterium avium subsp. paratuberculosis epitopes cross-reactive with human ZnT8 and 





Preface ……………………………………………………………………………………….……….………... 3 
Aknowledgments ……………………………………………………………………………….….…….……. 3 
Abbreviations …………………………………………………………………………………..….……..……. 4 




Most common types of diabetes …………………………………………………………………………. 8 
T1D ………………………………………………………………………………………………….………….. 
Epidemiology …………………………………………………………………………………………………… 






Genetic predisposition ……………………………………………………………………….…………….. 









High-incidence comorbidities …………………………………………...………………………………… 16 
Mycobacterium avium subsp. paratuberculosis ………………………………………………………. 
Features and transmission ………………………………………………………….………………………… 




Hypothesis and purpose of the study …………………………………………………………………… 18 
 














Magdalena Niegowska Conforti  – Immunogenicity of Mycobacterium avium subsp. paratuberculosis epitopes cross-reactive with human ZnT8 and 
proinsulin peptides in autoimmune diabetes – PhD Course in Life Sciences and Biotechnologies – Microbiology and Immunology – University of 
Sassari, Italy 
 

































VIII. Methods   
Subjects ……………………………………………………………………………………………………….. 
T1D-related autoantibodies and clinical testing …………………………………………………….... 
Peptide antigens …………………………………………………………………………………………….. 
Detection of Abs directed against peptide antigens …………………………………………………. 
In vitro stimulation of PBMCs with MAP3865c133–141 and ZnT8186-194 peptides ………………… 
Detection of cytokine levels ……………………………………………………………………………….. 
Flow cytometry analysis of cell populations and apoptosis ………………………………………… 






















Magdalena Niegowska Conforti  – Immunogenicity of Mycobacterium avium subsp. paratuberculosis epitopes cross-reactive with human ZnT8 and 






Most common types of diabetes mellitus 
 
Diabetes mellitus is a chronic condition associated with high blood sugar levels occurring 
when the production of insulin by the pancreatic β-cells is insufficient or when insulin-resistant cells 
fail to efficiently respond to the hormone. Insulin regulates the uptake of glucose by muscles and 
adipose tissue as a source of energy. Hyperglycemia, or raised fasting glucose, is a common effect 
of uncontrolled diabetes that over time leads to serious long-term complications such as neuropathy 
with subsequent muscle atrophy, damage of blood vessels resulting in retinopathy or nephropathy, 
and ketoacidosis due to enhanced lipolysis via the β-oxidation pathway. Life-long requirement for 
insulin therapy and medical supervision generate a significant economic burden on national 
healthcare services going hand in hand with the continuously increasing incidence of diabetes 
worldwide. The number of subjects affected by the disease are estimated to 422 million in 20141 




T1D is an autoimmune form of diabetes resulting from T-cell mediated destruction of 
pancreatic β-cells accompanied by a simultaneous production of Abs against islet cell targets. This 





 T1D accounts for about 5-10% of all diabetes cases and shows uneven distribution worldwide 
with over a 350-fold difference in incidence between countries4. Globally, the incidence of T1D 
presents elevated trends at higher geographical latitudes and in parallel to economic development5. 
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Notably, Sardinia registers the second incidence among children aged 0-14 years after Finland 
(44.8/100,000 and 64.2/100,000 cases each year, respectively)6-7 contrasted by China, India and 
Venezuela where autoimmune diabetes is uncommon (0.1/100,000; Figure 1)8. Several studies 
describe wide variations between genetically related and neighbouring populations such as Finnish 
children with a triple and six-fold risk compared to, respectively, Estonians9 and Russia Karelians10, 
or ten-fold difference between Omanis and patients from Saudi Arabia11. 
 
 
Figure 1. The global incidence of T1D among 0-14 year-old children. Values indicate the number of cases per 100,000 
people each year (from the International Diabetes Federation, 2015)12. 
 
 In contrast to other autoimmune diseases and studies in NOD models which show a strong 
female excess at onset13, T1D affects males and females equally with a slight male excess in high-
incidence populations14. This picture is inverted in low-incidence countries and ethnical groups of 
African and Asian origin15. Historically, Western populations had a low constant rate of the disease 
until the middle of the 20th century with a subsequent rise in incidence maintained until the present 
day16. However, marked regional differences reveal a levelling off in high-incidence countries such 
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Pathogenesis and diagnosis 
Although a progressive loss of β-cell function and the requirement for daily insulin treatment 
for patient survival has been apparent for over a century, the precise cascade of immunologic, 
genetic and physiologic events that guide disease onset and progression appear thus far 
incomplete19. The β-cells are crucial for glucose sensing and release of insulin to maintain correct 
sugar levels within a physiologically narrow range. In the recent years, the studies in animal 
models spontaneously developing autoimmune diabetes such as NOD mice have demonstrated that 
T1D occurs as a consequence of a breakdown in immune regulation, resulting in the expansion of 
autoreactive CD4+ and CD8+ T cells20-22, autoantibody-producing B lymphocytes23-25, and activation 
of the innate immune system that collaborate to destroy the insulin-producing β-cells26. 
Consistent with studies in humans, the hallmark of preclinical T1D is the infiltration of antigen-
specific T cells into the pancreatic islets27. Further β-cell damage leads to the release of self-
antigens followed by epitope spreading. In the peripheral blood of T1D patients, autoantibodies 
against several islet targets can be detected long before disease onset and are commonly used for 
prediction of increased risk and to distinguish T1D from other forms of diabetes.  
The likelihood of progression to T1D in autoantibody-positive individuals is influenced by 
factors linked to family history, age at Abs development, persistence and magnitude of the Abs 
response, Abs specificity (i.e. the presence or absence of certain epitopes known to be associated 
with high risk), and the number of detectable Abs types28. Abs against insulin (IAA) are usually the 
first to appear in young children and persist less among other classical autoantibodies29. Transient 
IAA titers in infants may result from maternal transfer but are not associated with progression to 
diabetes30. On the other hand, autoantibodies against the enzyme glutamic acid decarboxylase 
(GADA) are stable with age what makes them useful screening markers in young adults. The 
presence of Abs against zinc transporter type 8 protein (ZnT8A) is directly correlated with the 
age of T1D onset, whereas those directed against islet antigen-2 (IA-2A) are slightly more 
prevalent in younger cases and almost always detected in combination with other T1D 
autoantibodies. Both markers are supposed to indicate active β-cell destruction especially in late 
preclinical phase when they tend to cluster in association with a rapid progression to T1D and 
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increased diagnostic sensitivity31. Identification of at least two islet autoantibodies points at a 
significantly greater risk than a single autoantibody32-33 and accounts for 61% of probability to 
develop diabetes within 10 years in relatives with T1D history34. Similarly, individuals with multiple 
islet autoantibodies but no T1D family history appear to be at high risk35, however target specificity 
influenced by the strength of Abs binding determines the onset. For example, Abs directed towards 
the N-terminal GAD portion are associated with poor risk of T1D development, whereas Abs against 




 Although T1D is among the most common autoimmune diseases, knowledge regarding 
the factors contributing to its development remains incomplete. The interplay between 
environmental determinants and multiple genes has been considered as a complex cascade of 
events leading to the loss of immune tolerance towards self antigens. The genetic background 
has been considered a major contributor until twin and migration studies along with in-depth 
association analyses involving human leukocyte antigen (HLA) genotypes showed only partial 






 Genes affecting immune systems are supposed to strongly influence the development of 
T1D. HLA is a family of more than 200 proteins involved in immune recognition of body’s self 
components from exogenous antigens such as viruses or bacteria against which immune 
responses must be activated. While HLA class I are present on the surface of almost all cell 
types, HLA class II can be identified only on antigen presenting cells (APCs) including 
macrophages, dendritic cells or B cells and contribute to the activation of inflammatory 
responses or destruction of infected cells by displaying protein fragments to the immune system 
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that in turn recognizes their “self” or foreign origin. Fine mapping of a wide range of HLA variants 
confirmed that haplotypes strongly associated with T1D belong to HLA class II region37-38 and 
classify from protective to those with extremely high risk, for example HLA DR3/DR439 impacting 
on disease development in approximately 50%. 
 Linkage and association studies permitted to identify single nucleotide polymorphisms 
(SNPs) in non-HLA genes shared within affected populations. A variable number tandem repeat 
(VNTR) in the insulin gene promoter contains three classes of antigens with different impact on 
transcription rates and T1D risk linked to the impaired negative selection of insulin reactive T 
cells40. Yet, T cell self-reactivity may be increased by inherited changes in the expression of 
cytotoxic T-lymphocyte antigen-4 gene (CTLA-4) gene that in normal conditions inhibits ligand 
interactions within T cell receptor signaling complex41. The increased frequency of the 1858T 
allele in protein tyrosine phosphatase non-receptor 22 (PTPN22) gene have been reported 
among T1D individuals suggesting an incorrect control of spontaneous T cell activation42. 
Certain SNPs in interleukin 2 receptor alpha (IL2RA) may affect the maintenance of tolerance 
to self-antigens by reduced capacity to bind IL-2 leading to uncontrolled proliferation of 
regulatory T cells (Treg)43-44. Recent technologies employed in genome-wide association studies 
(GWAS) permitted to identify over 40 new genetic loci associated to T1D45 most of which 
involved in immune activation pathways such as toll-like receptor family46, chemokine receptor 
CCR547, interferon-induced helices C domain (IFIH1)48 or interactions between natural killer 
cells and HLA class I49-52, each adding only a minimal risk to disease onset (Figure 2). 
 Despite more sensitive identification methods, high risk genotypes have been less 
frequently detected among new T1D cases over the last half century53. As this time frame is not 
sufficient for the human gene pool to change, environmental pressure is attracting more 
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Figure 2. Currently mapped T1D non-HLA loci with respective chromosome locations and disease-associated SNPs 





Dietary components are the first source of exposure to exogenous substances in early 
life. While prolonged breastfeeding has generally been considered protective, the effect of cow’s 
milk proteins on β-cell autoimmunity provided contradictory results55-62 that, however, depend 
on geocultural preferences regarding milk formulas and types of complementary food to which 
infants are weaned. The recent Trial to Reduce Insulin-Dependent Diabetes Mellitus in the 
Genetically at Risk (TRIGR) evaluated the effects of weaning to an extensively hydrolyzed milk 
formula compared to a conventional milk based formula in Finnish babies with HLA-conferred 
T1D risk; after a 7-year follow-up period no differences in the incidence of T1D-associated 
autoantibodies was observed63. Likewise, a high consumption of cow’s milk in childhood does 
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not present a linear contribution to T1D onset in Scandinavian populations64-65 but the 
introduction of insulin-free formulas in the first 6 months of life reduces the cumulative incidence 
of standard T1D Abs by more than 60%66 which may be favored by limiting a possible cross-
reaction between bovine and human insulin that differ by only three amino acids. In a similar 
manner, gluten and other cereal-derived proteins were not confirmed as antigens driving the 
progression to T1D67-69. On the other hand, fatty acid status in the serum of breastfed children 
and the quantity of breast milk consumed per day negatively associated with islet 
autoimmunity70. 
 In relation to the increased T1D prevalence along with the distance from the equator, 
supplementation with vitamin D in childhood has been considered protective against the 
disease. Even though several studies confirmed this association71-73, low T1D incidence in some 
regions in Northern Europe74 and high incidence in Sardinia argue with these outcomes75. The 
accelerator hypothesis linked the raised velocity of β-cell apoptosis to excess weight gain that 
causes insulin resistance and weakening of glucose control76, therefore accelerated height may 
be a risk factor for progression to autoimmunity77. 
 Seasonal T1D onset trends pointed at a probable involvement of enteroviruses78; 
persistent infections may lead to the loss of pancreatic cells through a cytolytic effect or by 
induction of autoimmune processes due to molecular mimicry that results from the structural 
similarity between viral and β-cell epitopes79. This concept was addressed in a recent study 
involving six newly diagnosed T1D patients whose pancreatic biopsy tissue presented 
enteroviral capsid protein 1 and specific RNA sequences indicating a low-grade infection80. 
However, impossibility to confirm whether the enteroviral particles are a cause or consequence 
of β-cell failure together with low number of assessed patients and previous reports excluding 
such an association81-83 is far from explaining the role of viral factors. Yet, the transcription of 
non-protein coding HERV sequences integrated in the human genome as remnants of ancestral 
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 In some persons, sedentary lifestyle and improper diet linked to overweight may lead to long-
term metabolic alterations due to insulin resistance that result in increased release of glucose from 
the liver followed by hyperglycemia86. In contrast to T1D, the relative lack of insulin is mostly caused 
by reduced secretion of the hormone or by the inability of body tissues to respond to normal levels 
of insulin, without involving the autoimmune processes but including severe complications such as 
kidney failure, blindness, cardiovascular diseases and cognitive dysfunction. Chronic stress, 
epigenetic components and genetic risk contribute to the complexity of the disease87-88. Most 
predisposing genotypes are involved in β-cell functions and, among them, TCF7L2 allele consistently 
associated to T2D in linkage studies conferring a relative risk of about 1.489. To date, GWAS 
permitted to identify ~153 variants for T2D mapping with very few susceptibility loci shared with T1D 
that corroborate different mechanisms underlying the two forms of diabetes90. Genetic variants 
determine individual responses to the environment at the level of specific metabolic pathways; 





Latent autoimmune diabetes in adults is a slowly developing subtype of immune-mediated 
diabetes characterized by a combination of clinical features typical to T2D and reactivity to islet cell 
antigens commonly detected in T1D. GADA and IA-2A are the most conclusive biomarkers91 that, 
along with insulin independence period of at least 6 months following disease onset, permit to 
distinguish LADA from other forms of diabetes. Although general diagnostic criteria has been widely 
discussed92-93, GADA titers remain a benchmark for discrimination between phenotypes recognized 
among LADA patients presenting clinical characteristics closer to classical T1D or T2D94. 
 It is estimated that LADA accounts for almost 10% of newly diagnosed adult-onset diabetes 
cases, therefore its importance in terms of prevalence exceeds that of T1D. Nonetheless, LADA is 
far less investigated and its aetiology remains so far poorly understood. Even though some studies 
reported increased frequency of predisposing genotypes such as the T2D-associated variant in 
TCF7L2 transcription factor95 or HLA T1D-susceptibility haplotypes96-97, major occurrence of less 
protective genotypes98 and familial clustering linked to LADA pathogenesis99, hereditary factors 
alone cannot explain progression towards β-cell failure in subjects at low genetic risk. Despite its 
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phenotypically heterogeneous nature, LADA is a distinct entity frequently associated with other 
endocrine disorders100. The scientific literature describes environmental risk factors related to dietary 
habits and lifestyle101-105, however, unlike for T1D, scarce information is provided regarding infectious 






 Patients with diabetes show a greater prevalence for comorbidities compared to healthy 
population. T1D has been associated to other autoimmune diseases such as AIDT with up to 20% 
of T1D subjects bearing anti-thyroid autoantibodies that tend to increase with age and diabetes 
duration106. Additionally, GADA and ZnT8A are used as biomarkers of the risk to develop 
AITD107-108. Coeliac disease is observed in about 5% of T1D patients with the age at onset, female 
gender and concomitant AITD considered as predisposing factors109-111. These frequencies reflect 
the geographical incidence of T1D and, according to a Swedish study, the presence of coeliac-
specific autoantibodies has been reported in 62% of T1D subjects diagnosed with coeliac disease 
within 24 months following onset of diabetes112-113. Addison’s disease, polyglandular syndromes and 
collagenopathies co-occur with T1D to a lower extent114. 
 In LADA, high GADA titers were associated with the presence of anti-TPO Abs and a more 
severe autoimmunity profile, which specifically predisposed for AIDT115-116. In contrast, metabolic 
complications are the most common comorbidities of T2D. Association studies indicated increased 
risk for 27 autoimmune diseases among T2D patients, however the impact of environmental 
confounders that might favour the imbalance in glucose metabolism or, vice versa, facilitate the 
progression to autoimmunity, was not taken into account117.  
 
 
Mycobacterium avium subsp. paratuberculosis (MAP) 
 
 MAP is widely known as the causative agent of Johne’s disease affecting primarily ruminant 
livestock and defined by persistent gastroenteritis, progressive weight loss, reduced milk production 
and eventually death. Despite its worldwide distribution and over a century-long history of 
investigation, efficient diagnostic methods and prevention solutions are still unavailable due to the 
absence of symptoms in the first years after initial infection and to peculiar features of MAP with the 
very slow growth being the first drawback for strain characterization118. 
17 
 
Magdalena Niegowska Conforti  – Immunogenicity of Mycobacterium avium subsp. paratuberculosis epitopes cross-reactive with human ZnT8 and 
proinsulin peptides in autoimmune diabetes – PhD Course in Life Sciences and Biotechnologies – Microbiology and Immunology – University of 
Sassari, Italy 
 
Features and transmission 
 
  Similar to other mycobacteria, MAP has a lipid-rich cell wall that confers limited permeability 
to biocides and increased tolerance to stress induced by antibiotics, disinfectants and high/low 
temperatures that permit a long-time survival in the environment119-121. As an obligate pathogen, it 
developed particular metabolic adaptations allowing massive proliferation in the host at late stages 
of infection with specific tropism to the intestine122-124. Its ability to reside intracellularly in 
macrophages is possible through the inhibition of phagosomal maturation, thereby modulating or 
evading host cell defence mechanisms125-128. Moreover, gene clusters involved in metal transport 
along with those encoding putative siderophore synthesis and uptake systems129-130 help MAP 
overcome essential ions starvation induced by macrophages131-135.  
 Young animals are most susceptible to MAP infections due to a large number of M cells that 
form the main way of entry due to the lack of hydrolytic enzymes and inability to form mature 
phagosomes136. After a latency period, the mycobacterium is shed in feaces and milk which may be 
the source of feed contamination and oral transmission within herd. Even though MAP is not 
considered a zoonotic agent, it has been detected in a wide range of foods, primarily meat, milk, 
dairy products and infant formula, creating a potential risk of daily exposure for humans137-140. Many 
reports confirm that pasteurization process is not sufficient for a complete elimination of viable MAP 
cells, especially when isolated from human PBMCs141-143. 
  
 
MAP and human disease 
  
 In humans, MAP has been associated with CD considering symptoms similar to those 
observed in animals affected by Johne’s disease and a high frequency of MAP isolation from 
intestinal biopsies or PBMCs of CD patients144. Both diseases emerged in the same continents, 
today most affected by Johne’s disease: North America, Europe and Australia145, however the causal 
role of MAP has not been as yet ascertained. Some theories suggest that MAP invades and 
colonizes an already inflamed bowel146 as previously hypothesized for H. pylori and duodenal ulcer 
disease. Numerous investigators pointed at the contribution of the mycobacterium to UC based on 
the identification of the specific IS900 gene sequence present in several copies in the MAP genome, 
epidemiological evidences showing similar special and temporal distribution of UC and CD, as well 
as the development of both diseases in unrelated individuals living together147-148. 
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 Recently, MAP has been linked with other autoimmune diseases due to molecular mimicry 
between mycobacterial and human protein fragments. A transmembrane domain of ZnT8 expressed 
in endocrine cells including pancreatic islets and the thyroid shares amino acid sequence homology 
with a putative cation efflux MAP3865c which leads to the cross-reactivity and erroneous recognition 
of self and exogenous antigens. A few findings contribute to the strength of this association. ZnT8A 
are present in blood of patients affected by T1D and autoimmune thyroiditis but not in T2D subjects; 
in a similar fashion, high prevalence of Abs against MAP3865c has been reported in Italian children 
adults with established T1D or HT, while the same antigen elicited poor reactivity in T2D and healthy 
populations149-150. Likewise, Italian children at T1D onset showed increased levels of Abs against 
MAP-derived peptides homologous to ZnT8 and proinsulin151. Moreover, MAP DNA has been 
isolated from 63% individuals of a Sardinian T1D cohort and viable MAP cells have been successfully 
cultured from blood152-153.  
 Several studies described the involvement of MAP in diseases affecting the central nervous 
system. Positivity for IS900 detection tests and cross-recognition between EBV, MAP and myelin 
basic protein was reported in MS Sardinian patients with major prevalence when associated to 
polymorphisms in SLC11A1 gene involved in host resistance to intracellular pathogens and iron 
metabolism154-155. In a Japanese MS population, Abs response directed against MAP crude extracts 
appeared with a major frequency156. The role of MAP in disease pathogenesis has also been 
hypothesized for PD, even though not confirmed by cross-reactivity with homologous fragments of 
human zinc transporters157. 
  
 
Hypothesis and purpose of the study 
 
 Numerous sequence homologies existing between MAP and human proteins may potentially 
be on the bases of cross-reactivity enhancing organ-specific autoimmune responses. Both ZnT8 and 
proinsulin show amino acid stretches overlapping with several MAP components are involved in T1D 
pathogenesis as self-antigens. The ubiquitous nature of MAP, its ability to survive heat sterilization 
and, in turn, presence in foods may facilitate the transmission to humans. Even though latent MAP 
infection could persist asymptomatically, exposure to mycobacterial antigens generates the 
production of Abs and, in some subjects, loss of tolerance towards homologous peptides.  
The studies described in the present thesis aimed at evaluating seroreactivity against 
selected MAP-derived epitopes characterized by high sequence identity with human molecules in 
autoimmune diabetes and concomitant disorders. Time-related correlation with regard to the 
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appearance of the first classical autoantibodies, genetically-conferred risk and the phase of disease 
was performed with the purpose to characterize anti-MAP Abs as possible biomarkers for early 
prediction of T1D. Finally, selection of cohorts with distinct biogeographical and cultural background 
was performed in order to assess how different lifestyles and environmental conditions mirror 
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II. Seroreactivity of Sardinian newborns at risk for T1D  
 
This chapter is based on the following study: 
Niegowska M et al. Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children 
at Risk of T1D Precedes Detection of Classical Islet Antibodies. J Diabetes Res. 2016;2016:5842701. 
 
  The study involved the analysis of plasma samples obtained from Sardinian children enrolled 
in the TRIGR study, for the presence of Abs against selected MAP peptides and homologous ZnT8 
and PI fragments to identify possible biomarkers for early prediction of T1D development towards 
overt clinical disease. Moreover, peptides homologous to the human ZnT8 protein derived from H. 
pylori were assessed in order to achieve a picture of seroreactivity to a pathogen not associated with 
T1D and a possible cross-reaction with anti-MAP Abs. 
 
Results 
 In the study population, 10 out of 23 T1D ARS (43.48%) resulted positive for anti-
MAP1,4αgbp157-173 (M1) Abs, compared to 9.09% of HCs. The same prevalence among ARS was 
detected for the homologous PI64-80 (PI1) peptide, but only in 13.64% of HCs. 
 Abs against MAP2404c70-85 (M2) were recognized by 7 ARS (30.43%) and 13.64% HCs, 
while 6 ARS (26.09%) and 9.09% of HCs were positive for its homolog PI46-61 (PI2) (Figure 3).  
 Reactivity to MAP3865c133–141 (M3) was registered for 6 ARS (26.09%) and 9.09% of HCs, 
whereas 5 ARS (21.74%) resulted positive for the homologous ZnT8186-194 (Z1) peptide, comparing 
to 4.55% among HCs.  
 Anti-MAP3865c125-133 (M4) Abs were found in 5 ARS (21.74%) and in none of the HCs. 
Recognition of its homolog ZnT8178-186 (Z2) among the analyzed subjects accounted for 6 ARS 
(26.09%) and 4.55% of positivity for HCs.  
 Overall, 47.82% of children (n=11) reacted to any of the analyzed peptides compared to 
22.73% of age-matched HCs. A high degree of correlation (r2>0.9) was found between anti-MAP 
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Figure 3. Prevalence of Abs against MAP, PI and ZnT8 homologous peptides in children at risk of T1D and healthy controls. 
Sera were tested in duplicate for their reactivity against plate-coated peptides. Percentage of children with Abs positivity 
to any of the analyzed peptides is indicated by the first column pair. Dark bars represent children at risk of T1D; light grey 
bars correspond to HCs. 
 
 
Figure 4. Correlation between Abs recognizing MAP and its homologous human epitopes in Sardinian children at risk for 
T1D. Distributions relative to peptide pairs MAP1,4αgbp157-173/PI64-80 (A), MAP2404c70-85/PI46-61 (B), MAP3865c133–
141/ZnT8186-194 (C) and MAP3865c125-133/ZnT8178-186 (D) in 23 at-risk children. Each circle represents Abs of one ARS. The 
dotted lines indicate the cut-off for positivity used in each assay, as calculated by ROC analysis. 
 
 Interestingly, of the 23 ARS followed in time, 5 resulted positive for all the peptides 
MAP3865c133–141, MAP3865c125-133, MAP2404c70-85 and MAP1,4αgbp157-173, ZnT8186-194, ZnT8178-186, 
PI46-61 and PI64-80 (Table 6); in other 5 ARS, response to at least three peptides was registered. The 
highest reactivity among subjects positive for the assessed epitopes was observed for 
MAP1,4αgbp157-173/PI64-80 peptide pair, registered for 10 at-risk children (91%); two of them 
additionally recognized Abs against MAP2404c70-85/PI46-61 homologs and anti-MAP3865c125-
133/ZnT8178-186 Abs were found in one child. Four children presented Abs positivity against non-
homologous peptides MAP3865c133–141, MAP3865c125-133, MAP2404c70-85, ZnT8186-194 and PI46-61. The 
overlap in reactivity against homologous antigens among positive HCs (n=5) accounted for 40% and 
regarded only two subjects with Abs directed against at least 4 epitopes: one HC recognized 
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MAP1,4αgbp157-173/PI64-80 and MAP2404c70-85/PI46-61 peptide pair while the other one showed 
positivity to MAP3865c133–141/ZnT8186-194 and MAP2404c70-85/PI46-61 homologs. Non-homologous 
reactivity was detected for MAP1,4αgbp157-173, PI64-80, MAP3865c133–141, ZnT8178-186 and 
MAP2404c70-85.  
 Five of the positive children presented autoimmunity against either the studied peptides or 
classical islet antibodies. Furthermore, positivity to our peptides not only appeared before detection 
of classical autoantibodies within 6 months of age (Table 1), but was also maintained in time. 
Eventually, 3 ARS developed diabetes few years later demonstrating the importance of the studied 
peptides as potential preclinical biomarkers for diagnosis of T1D in subjects at risk for T1D. However, 
another child developed T1D even though antibody values were not significantly high, emphasizing 
the fact that T1D is determined by multiple factors contributing to disease manifestation. 
 Anti-HP Abs, either directed against J0I929_HELPX1-11 or T2T4W3_HELPX99-105, were 
detected in one ARS (4.35%) and the results were not statistically significant (p=0.82 and 0.18, 
respectively). No positive cases were observed among controls (Figure 5) and no correlation with 
progression to T1D or response to the analyzed peptides was found. 
 
Table 1. Age at detection of islet autoantibodies and immune reactivity to MAP, ZnT8 and PI homologous peptides in 
children at risk of T1D.  
 
a: Identity of children positive to the studied peptides or/and islet autoantibodies (n=12); highlighted patients progressed to T1D at 5, 4 
and 1,5 years of age, respectively; patient indicated in italics was lost during the follow-up. 
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Figure 5. Distribution of anti-HP Abs levels measured by ELISA in T1D at-risk subjects and healthy controls. Sera of 23 
ARS and 22 HCs were screened for Abs against J0I929_HELPX1-11 (A) and T2T4W3_HELPX99-105 (B). The dotted lines 
represent cut-off values calculated by ROC analysis and used to discriminate between positive and negative samples. 





 As numerous studies put in evidence the raising incidence of diabetes in children, an early 
diagnosis is of great importance to define a correct method of restraining disease development and 
to establish ulterior treatment. Even though genetic predisposition has been considered a crucial 
factor for T1D onset, less newly registered cases present genotypes of high or moderate risk158-163. 
Environmental factors seem to be critical in the pathogenesis of diabetes and include diet, infectious 
agents, perinatal and psycho-social conditions that vary among countries164. Several intracellular 
pathogens have been studied as possible T1D triggers, but none of them was proved to cause the 
disease.  
 Cow’s milk is the major mean of MAP transmission from infected cattle to humans. In 
developed countries, cow’s milk-based formulas are certainly a frequent source of exposure to 
exogenous complex proteins in postnatal life3. Nonetheless, after 7 years of the TRIGR follow-up no 
significant difference in progression towards β-cell autoimmunity was detected between children with 
HLA-conferred T1D susceptibility weaned to a conventional or an extensively hydrolyzed formula, 
the latter containing 99.7% of peptides with a molecular weight >2 kDa63. If initially present, survival 
of MAP cells exposed to enzymatic treatment is plausible; nevertheless MAP-peptides whose 
molecular weight ranges from 0.86 kDa for MAP3865c125-133 to 1.83 kDa for MAP3865c125-133, could 
persist in the hydrolyzed formula following enzymatic digestion and act as antigens stimulating T1D 
autoimmunity. Furthermore, breastfeeding continued during the study period could contribute to the 
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transfer of MAP, MAP-derived peptides or anti-MAP antibodies from mother to child. Macrophages 
are the most abundant cells in the breast milk counting 40-80% of cell fraction165 and the primary 
target of MAP. Studies on cattle with subclinical and overt Johne’s disease confirmed that MAP is 
shed into colostrum and milk during lactation upon its isolation in culture and by real-time PCR 
targeting IS900 MAP-specific gene166. Similarly, MAP has been isolated from human breast milk of 
few Crohn’s patients167, however research is required to assess the coincidence of T1D onset with 
the presence of MAP in mother’s breast milk and its transmission pathway to offspring. 
 MAP colonization of the mucosa lining the small intestine and the following uptake by M cells 
and enterocytes may play a triggering role in antibody production168. A contribution of MAP in 
inducing a latent infection in humans could result from molecular mimicry with ZnT8 and PI epitopes, 
leading to autoimmune responses. Cross-reactivity to the common target sequences and specificity 
of the homologous anti-MAP/ZnT8 Abs demonstrated recognition of a transmembrane domain of 
ZnT8 protein that cannot be evaluated by standard anti-ZnT8A tests which employ a fusion protein 
combining extra-luminal domains. The same ZnT8 region has a high homology with peptides derived 
from H. pylori already evaluated in association with autoimmune thyroiditis169; in contrast to MAP, 
anti-HP Abs were detected at very low levels with a similar prevalence in children at risk for T1D and 
the control group providing an additional support for the association of MAP with autoimmune 
diabetes. A high degree of correlation between the homologous peptides further points at their cross-
reactivity and segregation within the same sera.  
 Although anti-IAA are considered the first circulating Abs to activate islet cell autoimmunity170 
and the single β-cell-specific autoantigen in postnatal period, birth cohort studies revealed that IAA 
can be detected only from 6 months of age in children genetically predisposed for T1D171. In the 
present study, all human peptides and their MAP homologs resulted detectable during the first 6 
months after birth in 2 out of 6 positive children for which samples collected right after delivery were 
available. Response against insulin in three ARS partially followed positivity to the proinsulin 
peptides. One subject developed an early immunity against both PI peptides and their MAP 
homologs; regardless of missing anti-PI Abs in the other two children, although anti-MAP Abs were 
present in one of them, progression to diabetes was observed exclusively in these three cases 
(13,04%) during sample collection period and was accompanied by multiple islet autoimmunity. Two 
subjects positive to all the assessed islet autoantibodies were younger at T1D onset (17-18 months) 
compared to the subject with IAA, IA2A and ICA but negative for GADA (4 years). Children positive 
to ICA as a single autoantibody recognized at least five anti-MAP and the homologous peptides.  
 In the majority of cases positive to the eight analyzed peptides seroreactivity to most of the 
epitopes appeared at the same time-point. In contrast, children displaying incomplete responses to 
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MAP, ZnT8 and PI peptides presented an Abs pattern with gradual detection in the space of years. 
From the three cases of T1D onset, two were positive to at least one anti-MAP Abs detectable from 
6 months to one year prior to β-cell autoimmunity. In other children this gap was even longer, ranging 
from 2 to 8 years. The lack of response to any of the investigated peptides in the child who 
progressed to diabetes may be explained by a high-risk HLA genotype or other risk factors such as 
concomitant diseases or high frequency of T1D familiarity, however these data were not available 
owing to the double-blind design of the TRIGR study.  
 Unfortunately, individual formula treatment assignments cannot be disclosed due to the 
ongoing follow-up. Individual clinical data relative to the progression of diabetes-related 
autoimmunity following the TRIGR’s 7-year follow-up period are not revealed. Furthermore, samples 
covering the entire age range were not available for every participant, leading to the loss of an 
interesting subject with early response to all the analyzed peptides; lack of samples collected in the 
first months after birth for some children, including those who developed T1D, made the early Abs 
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III. Detection of anti-MAP Abs in Italian children and youths at T1D 
onset 
 
This chapter is based on the following studies: 
Niegowska M et al. Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies 
paratuberculosis epitopes homologous to human Znt8 and Proinsulin. Sci Rep. 2016 Feb 29;6:22266. 
Niegowska M et al. Seroreactivity against Specific L5P Antigen from Mycobacterium avium subsp. 
paratuberculosis in Children at Risk for T1D. PLoS One. 2016 Jun 23;11(6):e0157962. 
 
 Sardinian populations display a high genetic homogeneity stemming from the shared 
ancestry coupled with evolutionary forces172 and resulting in susceptibility to autoimmune diabetes, 
Considering the estimates that MAP infections among cattle herds in Sardinia are of particularly high 
frequency reaching 60%, exposure to MAP of an external population would occur with minor intensity 
providing an important ground for comparison of the two cohorts. In the this study, the Abs pattern 
involving seroreactivity to MAP-derived peptides and their human ZnT8/PI homologs was 
investigated in children and youth at risk for T1D from mainland Italy in order to verify whether the 
prevalence observed among Sardinian pediatric patients follows similar trends in a different 
biogeographical background. A correlation with classical islet autoantibodies was performed to 
evaluate a possible role of anti-MAP Abs as early predictive biomarkers. Moreover, time-point 
variations in Abs positivity were analyzed with reference to the further onset of T1D and risk factors 
including HLA genotype, concomitant diseases and familiarity. Occurrence and duration of cross-
reactivity due to epitope homology with human T1D autoantigens was further evaluated upon 





 Among 54 subjects at risk of T1D, 70.37% (n=38) resulted positive to at least one of the eight 
assessed peptides compared to 16.67% (n=7) of HCs. 78.95% (n=30) of the positive at-risk children 
had Abs targeting not less than four epitopes, 11.11% of whom were fully responsive to all peptide 
pairs. Considering healthy controls, multiple serum reactivity to at least three peptides was observed 
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 Upon single-peptide analysis of Abs reactivity, MAP3865c133–141 was recognized by 61.11% 
of at-risk subjects and by only 7.14% of HCs (AUC=0.72, p<0.0001). The highest immunoreactivity 
among at-risk children was detected for ZnT8186-194 and reached 62.96% in comparison to 7.14% 
among HCs (AUC=0.74, p<0.0001). 
 Serum Abs reactivity to MAP3865c125-133 accounted for 62.96% as well (AUC=0.80, 
p<0.0001), while recognition of the homologous ZnT8178-186 was observed in 51.85% (AUC=0.75, 
p<0.0001) of at-risk subjects, comparing to 4.76% of HCs for both peptides.  
 Concerning MAP homologs of proinsulin-derived peptides, anti-MAP1,4αgbp157-173 Abs were 
found in 22.22% of at-risk children and in 7.14% of HCs (AUC=0.58, p=0.17). Abs positivity against 
PI64-80 accounted for 16.67% among at-risk individuals, however prevalence among HCs maintained 
levels of 7.14% detected for the homologous peptide (AUC=0.57, p=0.19). 
 20.37% of at-risk subjects reacted to both MAP2404c70-85 and PI46-61 compared to 7.14% 
(AUC=0.54, p=0.53) and 9.52% (AUC=0.56, p=0.25) of positivity to the respective epitopes found 
among HCs. Figure 6 depicts percentages of each peptide pair. Interestingly, a slightly higher 
prevalence of positivity to MAP/PI peptides compared to MAP/ZnT8 was observed among HCs, in 
contrast to at-risk subjects presenting an inverse picture. 
 When time-point samples collected within further four years were analyzed for the presence 
of Abs against the homologous peptides, seroreactivity appeared maintained in 2 out of 3 at-risk 
subjects initially positive for the full set of epitope pairs. Similarly, Abs-negative status was constant 
in children (n=3) not demonstrating any response at the first blood collection. Fluctuations involving 
responses to the selected peptides were registered in subjects whose Abs positivity was at first 
incomplete (n=8), with the exception of two youth whose Abs status remained unvaried. Eight 
individuals lost their immune reactivity in the course of 1-3 years but not before the age of 5. These 
observations are reflected by changes in responsiveness over the time-points registering decreasing 
trends in prevalence of Abs against MAP/ZnT8 homologs and increased reactivity to MAP/PI, 
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Figure 6. Prevalence of Abs against MAP, 
proinsulin and ZnT8 homologous epitopes 
in T1D at-risk subjects and HCs 
(A) Distribution of Abs values based on the 
statistical analyses performed for all 
peptides separately. The dotted lines 
indicate thresholds of positivity relative to 
each assay calculated by ROC analysis. 
The percentage of Abs-positive at-risk 
subjects is reported on top of each 
distribution; horizontal bars specific for 
T1D and HCs groups correspond to 
means. AUC and p values (CI 95%) are 







(B) Percentage of children with Abs 
positivity to selected epitopes upon single-
peptide analysis. The first column pair 
summarizes reactivity to any of the 
analyzed peptides. Dark bars represent 
subjects at risk for T1D; light grey bars 
correspond to HCs.  
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Figure 7. Time-related prevalence of Abs directed against the homologous epitopes and classical islet autoantibodies in 
children at risk for T1D. (A) Three time-point variations in Abs reactivity to the four peptide pairs. MAP/ZnT8 homologs are 
indicated by black lines, while grey lines indicate MAP/PI homologous epitopes. (B) Time-dependent classical Abs status 
evaluated including ZnT8, GADA, IAA and IA-2A in 13 at-risk subjects. 
 
 The overlap between the homologous peptides in all samples of T1D at-risk subjects equaled 
83.87% for MAP3865c133–141/ZnT8186-194, 73.33% for MAP3865c125-133/ZnT8178-186, 41.38% for 
MAP1,4αgbp157-173/PI64-80 and 55.88% for MAP2404c70-85/PI46-61. Among HCs, this pairwise reactivity 
was complete for MAP3865c125-133/ZnT8178-186 followed by 50% for MAP3865c133–141/ZnT8186-194 and 
MAP1,4αgbp157-173/PI64-80, and reaching 40% of overlap for MAP2404c70-85/PI46-61. A high degree of 
correlation (r2>0.8) was found between anti-MAP and the respective anti-ZnT8/PI Abs titers with an 
even greater coefficient value (r2>0.9) for the MAP3865c125-133/ZnT8178-186 pair (Figure 8). 
 
 
Figure 8. Correlation between Abs recognizing MAP and its homologous human epitopes in Italian children at risk for T1D. 
Correlations are shown between Abs against (A) MAP3865c133–141/ZnT8186-194, (B) MAP3865c125-133/ZnT8178-186, (C) 
MAP1,4αgbp157-173/PI64-80 and (D) MAP2404c70-85/PI46-61. Each circle represents Abs detected in one sample. The dotted 
lines indicate cut-off points for positivity used in each assay, as calculated by ROC analysis. 
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 Upon sex-related analysis of at-risk children, females presented a higher prevalence of Abs 
directed against MAP/ZnT8 (59.26-74.07%, p<0.05), with a greater positivity obtained for ZnT8186-
194 and MAP3865c125-133 epitopes (Figure 9A). Prevalence to the same peptide pairs in males (44.44-
59.26%) reached the highest values for both MAP-derived peptides homologous to ZnT8. These 
trends, even though with lower percentages (14.81-18.25% vs. 14.81-25.93%), were inverse for 
MAP/PI homologs in both genders with the exception of PI64-80 for which females displayed a slightly 
higher prevalence. 
 Samples were further analyzed after grouping in two age ranges (0-9 and 10-18 years) 
showing 75% of prevalence to any of the analyzed epitopes in the younger group when compared 
to children older than 9 years for whom 61,9% of positivity was registered (AUC=0.56, p<0.04; Figure 
9B). However, a complete serum reactivity to the 8 peptides was found throughout different ages in 
both groups. Upon single-peptide analysis, the highest positivity was obtained at equal levels for 
MAP3865c133–141/ZnT8186-194 homologs (71.88%) within 0-9 years, while the lowest response in the 
same group corresponded to MAP2404c70-85 (15.63%). The 10-18 year-old children displayed the 
highest prevalence for MAP3865c125-133 (52.38%), whereas Abs against both proinsulin epitopes 
were less recognized (14.29%).  
 
Figure 9. Age/sex-related prevalence of Abs against MAP, proinsulin and ZnT8 homologous epitopes in T1D at-risk 
subjects based on a single-peptide analysis. (A) Sex-related Abs status of positive individuals is indicated by dark grey 
bars for females and light grey bars for males. (B) Analysis performed for 0-9 (dark grey bars) and 10-18 (light grey bars) 
year-old groups. The first column pair indicates reactivity to any of the analyzed peptides.  
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 Screening for classical islet autoantibodies in the first time-point samples revealed that ZnT8 
were the most frequent Abs detected in 58.82% of at-risk subjects for which Abs status was 
determined, followed by IA-2A (42.10%), GADA (40%) and IAA (28.95%; Table 7). This picture 
changed following to further time-related analyses available for 13 subjects (Figure 7B). Among at-
risk children with all measurements available, three (8.57%) resulted negative to both classical islet 
autoantibodies and the homologous peptides; one of them was affected by coeliac disease with 
impaired glucose tolerance and developed high IAA levels at the second blood collection.  
 Four at-risk children (13.79%) developed diabetes at the age of 6-11 years old with variable 
Abs status. One child was positive to IAA, IA-2A and ZnT8, the latter exceeding 1000 U/ml at T1D 
onset (9 years) and a complete reactivity to the 8 analyzed peptides. In contrast, a case with only 
ZnT8 measurements performed became Abs-negative when diagnosed one year later (11 years); 
likewise no Abs targeting MAP or the homologous epitopes were detected. Only one child developed 
a full set of classical islet autoantibodies at T1D onset (6 years) but not responded to the homologous 
peptides. A complete Abs response detected in another case at the second blood collection reduced 
to GADA and IA2A two years later at T1D diagnosis (11 years); this trend had a similar final for the 
investigated epitopes as the Abs pattern initially positive to anti-MAP/ZnT8 Abs (9 years) switched 
to MAP2404c70-85 and PI46-61 at the second blood collection one year later and reduced to no 
response at T1D onset. 
 Out of five subjects considered at high T1D risk due to their classical Abs status, one 
displayed initially a complete response to islet autoantibodies; this ratio increased to four upon further 
time-point analyses following fluctuations of Abs levels. Considering children at low or moderate risk 
for T1D, 42.85% were at first positive to multiple classical islet autoantibodies, while 17.86% subjects 
presented single Abs reactivity; however, data relative to the measured Abs levels were not available 
in some cases (Table 7). Further analysis of time-point samples revealed an almost unvaried 
prevalence of positivity to at least two classical islet autoantibodies (42.31%) while reactivity to single 
Abs increased twice (34.61%); individuals who lost or maintained their Abs negativity accounted for 
23.08%.  
 Among subjects with a complete Abs identification, 55.56% of children positive to at least two 
classical autoantibodies reacted to non less than 4 homologous peptides, while no response was 
registered in 22.22%. On the other hand, individuals negative to classical islet autoantibodies 
presented the same levels of positivity to the analyzed epitopes. Both percentages equaled 33% in 
children positive to only one classical autoantibody. Of the six cases with a complete response to 
the homologous MAP and ZnT8/PI peptides, 16.67% showed a full set of classical autoantibodies, 
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 37.78% (n=17) of at-risk subjects had high-risk HLA genotypes, however only 17.64% (n=3) 
of them developed T1D and 58.83% were positive to at least half of the analyzed MAP-derived and 
ZnT8/PI homologous peptides. Another child who progressed to diabetes had a low risk HLA 
genotype and reacted to MAP3865c133–141/ZnT8186-194, MAP3865c125-133 and MAP2404c70-85/PI46-61. 
Males accounted for 58.82% of at-risk subjects with a high-risk HLA genotype, however the ratio of 
T1D onset between genders equaled 1:1. 54.05% of subjects with low-risk genotypes responded to 
at least four epitopes, whereas 50% of individuals with HLA DQA1*0501/DQB1*0201 and 
DQA1*0201/DQB1*0202 genotypes resulted negative. 
 When Abs status against the selected epitopes was analyzed in correlation with concomitant 
diseases in subjects at risk for T1D, 82.35% of children affected by coeliac disease or with coeliac 
familiarity resulted positive to at least two peptides. All individuals with autoimmune thyroiditis 
occurring alone or combined with coeliac disease reacted to at least four peptides including both 
MAP/ZnT8 homologous pairs. Among children with T1D familiarity, positivity to at least two epitopes 
was detected in 53.84% of cases. The lowest ratio (42.86%) was obtained for subjects suffering from 
occasional hyperglycemia, impaired glucose tolerance and/or obesity. Progression to T1D was 
associated with the disease familiarity coupled to a high-risk HLA genotype in two cases and a 
complete Abs positivity to the homologous peptides in one of them, whereas no Abs response was 
registered in the other one. Occasional hyperglycemia characterized the other two children at T1D 
onset, one of which without high genetic risk. 
 A full set of Abs directed against MAP and the homologous epitopes was observed in three 
cases with T1D familiarity and three cases with coeliac disease or familiarity, whereas immune 
responses to the peptides were absent in 38.46% of children with T1D familiarity, 57.14% suffering 
from occasional hyperglycemia and 11.76% with coeliac disease or familiarity. No correlation with 
age, high-risk HLA genotype or concomitant diseases was found for any of the classical 
autoantibodies.  
Further analysis of Abs responsiveness to L5P was performed in order to specifically validate 
seroreactivity in relation to the four homologous peptide pairs. 81.25% of children at risk for T1D and 
16.67% of HCs were positive to at least one of the eight homologous peptides. Reactivity to L5P 
antigen was lower among at-risk subjects and accounted for 54.12%, whereas responses in Hs 
reached 19.05%. Nevertheless, the difference between means relative to L5P-positive cases and 
HCs was not markedly pronounced and the results did not attain statistical significance (Figure 10A). 
MAP-derived epitopes homologous to human ZnT8 showed the highest and equal correspondence 
with levels of anti-L5P Abs, thus MAP3865c133–141 has been chosen as a representative peptide for 
further analysis. Similarly, our previous results demonstrated remarkable prevalence (>60%) of Abs 
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directed against both MAP/ZnT8 homologs with high degree of statistical significance (p<0.0001) in 
comparison to values obtained for MAP/PI homologs (prevalence <23%). In this study, the initial 
seroreactivity to MAP3865c133–141 among T1D at-risk subjects was higher compared to that of L5P 
and reached 65% but followed a decrease to 50% when samples relative to the last blood collection 
were included. Prevalence among HCs accounted for only 7% and the results were highly significant 
(p<0.0001, Figure 10B). Both epitopes presented a 1:1 ratio of Abs positivity between males and 
females. When genders were assessed separately, prevalence among girls was higher than in boys 
(92.3% vs. 63.7% for the homologous peptides and 69.2% vs. 42.1% for L5P). 
 
 
Figure 10. Prevalence of Abs against L5P and MAP-derived ZnT8 homolog in T1D at-risk subjects and HC. Plasma 
samples were analyzed in duplicate for Abs directed against L5P (A) and MAP3865c133-141  (B) epitopes. Distributions are 
relative to the sample sets including only the first or the last time-point collection in comparison to HCs. Horizontal bars 
indicate means. The dotted line corresponds to the Abs positivity threshold. AUC and p-values relative to T1D at-risk 
subjects vs. Specific percentage of reactivity is indicated above each distribution. 
Upon analysis of time-point samples, a stronger correlation between titers of Abs directed 
against MAP3865c133–141 and L5P was observed among HCs and T1D at-risk subjects including 
values relative to the last blood collection compared to T1D at-risk children considering the first time-
point samples (Figure 11). Children who maintained in time anti-MAP Abs positivity displayed a 
continuous response to L5P antigen, whereas loss of immunity against MAP epitopes was mirrored 
by reduced anti-L5P reactivity leading to a decrease of Abs levels below the established threshold. 
In these terms, coincidence in positivity to both MAP homologs and L5P antigen reached 90.63% in 
T1D at-risk subjects and 90.48% in HCs, pointing at the presence of immune responses independent 
from cross-reactivity observed for the homologous epitopes. 7 out of 11 children for whom time-point 
samples were available lost their positivity to MAP-derived homologous peptides. There were no 
cases of time-related acquisition of either anti-MAP or anti-L5P reactivity among the selected 
samples (Table 2).  
34 
 
Magdalena Niegowska Conforti  – Immunogenicity of Mycobacterium avium subsp. paratuberculosis epitopes cross-reactive with human ZnT8 and 
proinsulin peptides in autoimmune diabetes – PhD Course in Life Sciences and Biotechnologies – Microbiology and Immunology – University of 
Sassari, Italy 
 
Principal component analysis confirmed the association of Abs levels against MAP/human 
homologs with L5P but revealed a weak relationship between HLA genotype and reactivity to either 
homologous peptides or L5P antigen (Figure 12). Among L5P-positive subjects, 46.67% had a low-
risk genotype, 55.55% moderate and 25% high genetic predisposition for T1D. Interestingly, in the 
study population, most of the high- and moderate-risk genotypes were found among males indicating 
an increased probability for the development of clinical symptoms by the combination of 
sex/genetics-related factors173. Age and the presence of islet cell autoantibodies were not associated 
with anti-L5P Abs levels or general positivity to L5P. 
 
 
Figure 11. Correlation between Abs recognizing MAP-derived epitope and L5P antigen in children at risk for T1D and HC. 
The distributions represent correlations between Abs against MAP3865c133–141 and L5P in T1D at-risk subjects including 
samples of the first time-point (A) or the last time-point (B) and HCs (C). Each circle corresponds to Abs detected in one 
sample. The dotted lines indicate cut-off values used in each assay to discriminate between positive and negative samples. 
R2 coefficients are given for each distribution. 
 
Figure 12. Principal component analysis of 
variables describing relationship with 
positivity to L5P in samples of children at 
risk for T1D. Bi-plot illustrates correlation 
between levels of anti-L5P Abs and 
variables relative to T1D genetic 
predisposition, available demographics 
data and titers of Abs against MAP-derived 
and human homologous peptides. Children 
reactive to L5P antigen are indicated by 
squares whereas circles correspond to 
negative samples. All variables are 
described by labels and their position on the 
plot is indicated by triangles. The 
distribution shows relationship between PC1 and PC2 explaining 67.67% of the total variation. Only samples of children 
with known HLA genotype are included. 
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Table 2. Clinical characteristics and Abs status in T1D at-risk subjects. Plus signs and hyphens indicate, respectively, the 
presence or absence of available time-point samples, Abs directed against MAP homologous peptides and L5P antigen 
with their maintenance in time, as well as coincidence of Abs status for both types of epitopes.  
N. Patient ID Gendera Ageb Time-point samples Abs positivity Abs maintenance
c Coincidenced 
MAP L5P MAP L5P 
1 1 M 12.65 - + +   + 
2 2 F 9.22 - + +   + 
3 3 F 4.08 - + +   + 
4 4 M 5.61 - - -   + 
5 5 M 18.89 - - -   + 
6 8 F 8.61 + + - - - + 
7 9 M 4.91 + + + + + + 
8 10 F 4.76 - - -   + 
9 11 F 9.71 - + +   + 
10 12 M 8.15 - - -   + 
11 13 M 5.31 - + +   + 
12 14 M 6.43 - + +   + 
13 16 F 7.16 - + -   - 
14 22 M 7.97 + + + - - + 
15 23 M 12.87 + + - - - + 
16 24 M 5.74 + + - - - + 
17 26 F 6.32 + + + + + + 
18 27 M 7.18 + + - - - + 
19 31 M 12.92 - - -   + 
20 33 M 15.12 + + + + + + 
21 34 F 5.09 + + + + + + 
22 35 M 8.12 - + -   - 
23 36 M 3.97 - - -   + 
24 43 M 10.4 - + -   - 
25 48 F 11.86 - + +   + 
26 52 M 9.12 - + +   + 
27 53 F 10.02 + + - - - + 
28 54 F 14.06 - + +   + 
29 55 F 11.41 - + +   + 
30 56 M 9.84 - + +   + 
31 57 M 9.99 + + - - - + 
32 58 F 7.36 - + +   + 
a F: females, M: males. b Age at blood collection; relative to the first sample for subjects with multiple time-point collections. 
c Given only for subjects for whom time-point samples were available. d Calculated based on the Abs status against MAP 




 The present results are in line with the earlier outcomes involving T1D at-risk Sardinian 
subjects enrolled in the TRIGR project. Both studies registered a high serum reactivity to MAP-
derived epitopes in comparison with healthy individuals; while Sardinian children responded better 
to MAP/PI homologs, in the present work a particularly high prevalence was obtained for MAP/ZnT8. 
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The difference may be due to a younger mean age of the Sardinian participants with follow-up not 
exceeding 10 years old in most cases. This picture changed further upon the analysis of time-point 
plasma samples portraying downward trends of positivity to MAP/ZnT8 homologs and proinsulin 
peptides, paralleled by an increased response to MAP1,4αgbp157-173 and MAP2404c70-85. 
 In contrast to evidences claiming IAA as the first circulating autoantibody produced by 
subjects genetically susceptible to or affected by T1D and being their levels inversely proportional 
to age170, IAA prevalence in the present cohort increased during follow-up. An opposite trend was 
followed by Abs against classical ZnT8 epitopes that diminished by almost 35%. Interestingly, levels 
of anti-MAP/ZnT8 Abs declined as well with further time-related analyses. Prevalence of GADA 
decreased slightly in consonance with reports describing its appearance pattern in distinct age 
periods174.  
 A cross-reactivity of the analyzed peptides is emphasized by the overlap between the 
homologous peptides that exceeds 80% for MAP/ZnT8. The pairwise positivity was lower in case of 
MAP/PI homologs, probably caused by a gradual loss of immunity with increasing age as registered 
for IAA. Among IAA-positive subjects, 45.45% had Abs directed against MAP/PI epitopes; this 
number equaled 25% in IAA-negative children. In contrast, reactivity to MAP/ZnT8  homologs 
accounted for 66.67% among individuals positive to classical ZnT8A and reached 80.95% among 
those without anti-ZnT8 Abs. This difference, however, could be attributed to a possible future 
implication of autoimmune thyroiditis. Coincidence of autoimmune diseases, with AITD most 
frequently complicating T1D, is well known to the scientific literature175, therefore positivity to ZnT8-
derived homologous peptides may indicate an increased risk for multiple autoimmune syndrome. In 
fact, all patients suffering from autoimmune thyroiditis were positive to the analyzed peptides. This 
ratio was still high for coeliac disease (82%) but much lower in case of other concomitant symptoms 
such as occasional hyperglycemia, impaired glucose tolerance and/or obesity (42%). An estimated 
familial clustering accounts approximately for 40-50%176 and in this study was reflected by immune 
reactivity to MAP-derived epitopes and their homologs. Moreover, male sex has been considered a 
T1D risk factor for siblings177; an equal ratio of positivity to the homologous peptides in males and 
females could point at a combined gender-related effect, even though, in contrast to autoimmune 
thyroiditis concerning prevalently women, boys and girls are equally affected by T1D in young 
populations178. 
 A much higher female reactivity to MAP/ZnT8 may be predictive of a further AITD onset. 
Classical anti-ZnT8 Abs along with high GADA titers have been considered a risk biomarker for AITD 
in LADA patients108. Males presented a higher response to MAP-derived homologs of proinsulin in 
different age periods suggesting the impact of differing immune responses to early environmental 
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exposures. In both genders, Abs against MAP/PI always appeared accompanied by responses to 
MAP/ZnT8; furthermore, positivity to all four MAP/PI homologs was present only with a complete 
reactivity to MAP/ZnT8 hinting at a high sensitivity of the former epitopes indicating the asymptomatic 
phase of prediabetes. 
 Numerous reports evaluating genetic factors in the development of T1D confirm that HLA-
DQ2 and HLA-DQ8 haplotypes strongly predispose to the disease. Yet, heterozygous individuals 
have increased susceptibility compared to homozygous subjects, in particular DR3/DR4 genotype, 
confers the highest risk for T1D179-180. In this view, 62.22% of the analyzed samples had low-risk or 
protective genotypes, however 3 out of 4 cases who progressed to overt diabetes carried a high-risk 
HLA genotype. Regardless epidemiological studies indicate <10% of high-risk genotypes 
progressing to islet autoimmunity, 58% of subjects with HLA-conferred susceptibility presented 
multiple reactivity to the homologous peptides. A slightly lower prevalence among children with low-
risk genotypes confirms the previous association of anti-MAP Abs with HLA DQA1∗0201/DQB1∗0202 
at T1D onset181 that, together with HLA DQA1*0501/DQB1*0201, in the present study were the most 
frequent genotypes and corresponded to 50% of positivity to the homologous epitopes, whereas 
immune reactivity linked to DQA1*0201/DQB1*02 was displayed by 4 out of 5 children. Furthermore, 
these genotypes confer the highest risk for coeliac disease in homozygous individuals182. A greater 
number of individuals should be analyzed in order to investigate further the association of MAP with 
HLA genotypes and hypothesize a possible promotion of molecular mimicry between the selected 
peptides and islet autoantigens.  
 More cases positive to MAP/ZnT8 registered among at-risk children and a poor reactivity 
among HCs are in contrast with prevalence of Abs against MAP/PI homologs presenting a 
diminished at-risk subject/HCs ratio (3,31:1 for MAP/PI vs. 12,9:1 for MAP/ZnT8); the resulting low 
statistical significance of data relative to anti-MAP/PI responses might be improved by recruiting a 
higher number of participants. Possible changes of immune responses against the peptides and an 
early status of classical Abs should be evaluated at younger age including blood collection at birth, 
in order to verify whether the previous findings relative to Sardinian children at risk for T1D may be 
similar in other populations. At present, much higher responses to all MAP/ZnT8 homologs were 
observed in children younger than 10 years old; interestingly, both proinsulin epitopes followed a 
similar trend, whereas more cases positive to Abs against their MAP-derived homologs were 
detected in the 10-18 years group.  
Significantly high responses to the above-mentioned peptides were further compared with  
seroreactivity to L5P as a specific MAP antigen. Considering the particular structure of L5P that lacks 
a free hydroxyl group in its core and presents an unmodified saturated fatty acid in the N-terminal 
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domain183, several ELISA protocols were tested, however the best sensitivity has been achieved 
applying the same procedure and antigen concentration as for the other epitopes. In result, anti-L5P 
responses were higher in children at risk for T1D than in HCs but not statistically significant, in 
contrast to the other MAP-derived antigens. Abs prevalence to L5P and the four MAP peptides 
analyzed together resulted similar in HCs while differed greatly in at-risk subjects (81.25% vs. 
54.12%, respectively).  
When initial reactivity to L5P was compared to responses against only MAP3865c133–141 
peptide presenting the most similar positivity pattern, Abs prevalence appeared much higher in HCs 
(19% vs. 7%, respectively) and quite lower in children at risk for T1D (54% vs. 65%, respectively). 
Interestingly, seroreactivity against either single MAP3865c133–141 or the entire group of MAP-derived 
and the homologous human epitopes was almost identical as that elicited by L5P antigen upon 
inclusion of samples relative to further time-point blood collections, resulting in the final Abs 
coincidence exceeding 90%. This phenomenon was due to the time-related loss of anti-MAP Abs in 
some children mirrored by the absence of positivity to L5P. It is plausible that MAP-derived homologs 
cross-react with ZnT8 and PI peptides at a young age inducing initially immune responses in subjects 
predisposed for T1D that are subsequently attenuated. As suggested for Crohn’s disease, Abs 
prevalence among healthy controls and individuals who don’t progress to overt diabetes may result 
from latent infection or past exposure to MAP in early childhood conferring some natural 
protection145. 
ZnT8A and IAA, together with other islet cell antigens, are standard biomarkers indicating an 
increased risk for T1D, especially in cases of multiple Abs positivity. Although, they cannot be 
detected during the first months after birth and their levels decrease with age. As previously observed 
in Sardinian children at risk for T1D, immune responses to MAP peptides appear before classical 
Abs used for T1D diagnosis, however in many cases they tend to attenuate. In this context, L5P 
might have a general diagnostic potential but, in the analyzed samples, it was not sensitive to 
changes in seroreactivity against MAP registered for the other epitopes. Nonetheless, positivity to 
L5P in HCs corresponded to values below the cut-off point obtained for MAP-derived and human 
homologous peptides, and was reflected by a significant correlation performed for MAP3865c133–141. 
On the other hand, L5P may be helpful to immediately indicate the presence of anti-MAP Abs when 
evaluation of a more complex Abs status, achievable by the application of the homologous epitopes, 
is not required, avoiding false-positive results due to temporal cross-reactivity. 
This study provides evidences that either protein or lipid MAP antigens may induce similar 
Abs responses in terms of strength, while somewhat higher specificity corresponding to the optimal 
positivity threshold characterized the selected MAP peptides. Since L5P has been described as 
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more specific than the current diagnostic test for Johne’s disease based on MAP purified protein 
derivative183, almost complete coincidence in responses to both types of antigens used in the present 
study lends support to the involvement of anti-MAP Abs in T1D. Higher prevalence of Abs against 
L5P and MAP-derived peptides in subjects with low and moderate T1D risk conferred by HLA 
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IV. Humoral and cell responses to MAP-derived epitopes in Polish 
T1D youths 
 
 This study was performed with the purpose to evaluate differences in the recognition of MAP 
and human homologous antigens in a population of young T1D patients with a distinct 
biogeographical and cultural background compared to the previously selected cohorts. Humoral and 




 Upon the analysis of seroreactivity, major differences of mean values between T1D and 
control subjects were registered for PI46-61 that corresponded to 28.38% of T1D patients above the 
cut-off for positivity compared to 7.69% among controls (p<0.001, AUC=0.708, Figure 13A), followed 
by its homolog MAP2404c70-85 accounting for 27.03% and 11.54%, respectively (p<0.008, 
AUC=674). Nonetheless, statistical significance was attained only for the PI peptide when 
considering the numbers of positive and negative individuals in both groups (p<0.03), even though 
the value relative to the homologous MAP-derived epitope was close to the threshold of significance 
(p<0.06).  
 The second MAP/PI pair provided a lower Abs prevalence translated into 16.22% of positive 
T1D patients and only 3.85% among controls (p<0.013, AUC=0.663) for MAP1,4αgbp157-173, while 
the homologous PI64-80 was recognized in a similar fashion by the two groups (21.62% vs. 19.23%, 
respectively) and lacked statistical significance. 
 Concerning MAP/ZnT8 peptide pairs, a higher seroreactivity among patients was observed 
for MAP3865c125-133 and corresponded to 25.68% of positive T1D individuals compared to 11.54% 
among controls. The homologous ZnT8178-186 triggered even more elevated Abs responses 
accounting for 29.73% and 15.38% of positivity in the respective groups. 
 Serum Abs reactivity to MAP3865c133–141 displayed higher levels among controls (19.23%), 
although the prevalence relative to T1D subjects was only slightly lower (17.57%). Comparable 
immunoreactivity among both groups was registered also for ZnT8186-194 (16.23% for T1D vs. 15.38% 
for controls). Results obtained for MAP/ZnT8 pairs were not significant due to similar mean values 
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Figure 13. Prevalence of Abs against MAP-derived and homologous human antigens in whole study population (A) and 
separately in males (B) and females (C) with the relative percentage of positive subjects: Dark bars represent T1D patients; 
light grey bars correspond to HCs. (D) Distributions representative for male participants; each dot corresponds to values 
obtained for a single sample in separated ELISA tests with plate-coated peptides. Black points: T1D males. White circles: 
control males. Means (horizontal bars) and statistically significant differences are indicated (Mann-Whitney). 
 
 Sex-related analysis explained the picture of general responses. T1D males displayed 
particularly high Abs prevalence to PI46-61 (p<0.005, 40.74%) and a lower percentage of positive 
cases compared to controls (22.22% vs. 33.33%, respectively) when considering the other PI 
peptide (Figures 13B and 13D). Raised Abs levels against both MAP-derived antigens homologous 
to proinsulin were observed among T1D subjects regardless of gender, however only males showed 
significant values for MAP3865c133–141 (p<0.014). Interestingly, PI64-80 did not trigger elevated Abs 
reactivity among female controls (Figure 13C). On the other hand, obese girls presented more 
elevated seroreactivity to MAP3865c133–141/ZnT8186-194 than T1D females inversely to the trend 
observed among males and highly contributed to level off the responses seen in the general analysis 
for this peptide pair. Even though the difference in Abs responsiveness to MAP3865c133–141 between 
T1D and HC males was not marked (14.82% vs. 10%, respectively), statistical significance of the 
means was on the threshold point (p<0.051). In contrast, males displayed similar Abs prevalence for 
MAP3865c125-133 among both T1D and HCs but the response to its ZnT8178-186 homolog was much 
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  In order to evaluate the cytokine expression profile, PBMCs of a pilot cohort (n=11 T1D 
patients and n=3 controls) were stimulated with MAP3865c133–141 or ZnT8186-194 peptide selected 
initially as a representative pair of MAP/human homologous antigens. Both antigens were able to 
induce particularly increased specific production of IL-1β and IL-12p40 in T1D with even higher levels 
registered for control subjects (Figure 14A). A similar trend was observed in the expression of INFγ 
upon stimulation with the MAP-derived homolog only, while ZnT8186-194 corresponded to decreased 
INFγ levels among T1D patients without inducing changes in controls. Interestingly, T1D subjects 
expressed a diminished production of TNFα after incubation with each epitope that contrasted the 
results relative to the obese individuals. 
 
 
Figure 14. Cytokine expression in PBMCs following to immunostimulation with MAP3865c133–141 (P1) and ZnT8186-194 (P2) 
antigens. CD28/49d was added as a co-stimulator to wells containing the selected peptides. The concentrations were 
determined from cell culture supernatant after 18h for IL-1β and TNFα or 72h for INFγ and IL-12p40. (A) Analysis between 
T1D and control subjects. Each dot corresponds to a single sample and horizontal bars indicate means. Black points: T1D 
patients. White circles: control subjects. (B) Analysis based on anti-MAP positivity in T1D patients. Dark bars: MAP-positive 
(n=4); light grey bars: MAP-negative (n=7). 
 
 Cytokine profiles was further assessed for the T1D group in the context of Abs positivity to 
the antigen pair (Figure 14B). For IL-1β, the expression reached elevated levels with somewhat 
higher values among Abs-positive subjects. Likewise, IL-12p40 was highly induced compared to 
untreated samples, however a slightly lower levels corresponded to the seroreactive individuals. An 
incisive difference was observed for INFγ produced at raised levels in MAP-stimulated cells by 
patients who presented Abs against the selected homologous pairs with almost unchanged 
concentrations in Abs-negative subjects. In samples incubated with ZnT8186-194, INFγ expression 
decreased in both groups. A comparable reduction in TNFα levels was displayed by each group 
regardless of reactivity to the eight epitopes. 
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 Flow cytometry analysis performed in order to evaluate the degree of cell apoptosis following 
the immunostimulation showed lower number of live PBMCs in conditions including the selected 
peptides compared to untreated cells (Figure 15). The percentage was comparable between T1D 
and control individuals for MAP3865c133–141, while for ZnT8186-194 less live cells were registered for 
the obese patient. Labeling with annexin V that specifically binds to phosphatidylserine normally 
found on the intracellular side of the plasma membrane permitted to identify cells during early 
apoptosis when phosphatidylserine translocate to the external leaflet. The levels of apoptotic cells 
increased for all samples incubated with either MAP3865c133–141 or ZnT8186-194, particularly in the early 
stages. Necrotic cells were detected by staining with 7-AAD that has a high DNA binding constant 
and permits to identify cells in more advanced apoptotic processes such as the loss of membrane 
integrity and DNA fragmentation. However, slightly elevated necrosis corresponded to ZnT8186-194 
stimulation in the control sample only. 
 
 
Figure 15. Cell apoptosis in PBMCs stimulated with MAP3865c133–141 (P1) and ZnT8186-194 (P2) antigens. The histogram 
shows percentage differences in the relative apoptosis phase analyzed in n=1 T1D and n=1 control subject following 72h 
of cell culture. Cytometry charts illustrate cell gating based on 7-ADD labeled with PerCP-Cy5-H and Alexa Fluor 
488-conjugated annexin V staining in the T1D sample. 
 
 The phenotypical characterization of T-cell population showed a significantly elevated 
percentage of CD3+ cells in samples stimulated with each peptide compared to negative control 
conditions (Figure 16). T1D patients showed significantly raised CD3+ levels in comparison with 
control subjects, however higher values were detected for these subjects also in the untreated PBMC 
cultures (p<0.03 for MAP3865c133–141 and p<0.00003 for ZnT8186-194). When considering T1D patients 
positive or negative to anti-MAP Abs, the serological differences were not reflected by the 
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percentage of lymphocytes but still the ability of both epitopes to induce T cell proliferation was 
marked. Only ZnT8186-194 induced a significant increase in CD3+ levels respect the unstimulated 
culture (p<0.003 for anti-MAP Abs-positive and p<0.01 for anti-MAP Abs-negative subjects). 
 To evaluate the responses of monocytes following the incubation with the homologous 
antigens, PBMCs were simultaneously stained for CD14+/CD16+ subset. Elevated levels were 
observed for both peptide-stimulated conditions, however neither of them permitted to attain 
statistical significance (Figure 16). What is more, control subjects displayed even higher cell 
percentage. In contrast, responses of monocytes among T1D patients positive for Abs against MAP 
epitopes were markedly raised for each peptide compared to seronegative subjects, although the 
content of CD14+/CD16+ subset was higher also in the untreated cultures. Significant difference 
between stimulated cells and the negative culture was obtained only for MAP3865c133–141 (p<0.04). 
 
 
Figure 16. Immunofluorescence analysis of CD3+ and CD14+/CD16+ populations in PBMCs stimulated with 
MAP3865c133–141 (P1) and ZnT8186-194 (P2) peptides to which CD28/CD49d was added as a co-stimulator. (A) Comparison 
between T1D patients (dark bars) and control subjects (light grey bars). (B) Assessment in T1D patients positive (dark 
bars) or negative (light grey bars) to anti-MAP Abs. Statistically significant results for T1D group are indicated by asterisks. 
 
 Patients with a complete data regarding demographics, clinical history and nutritional habits 
were selected from the study population for the correlation analysis with the presence of Abs directed 
against the assessed peptide set. Based on several reports associating MAP to diet and its possible 
transmission with contaminated food, the evaluation was restricted to variables describing patients’ 
dietary preferences and other factors linked to predisposition for autoimmune diseases. Multivariate 
analysis permitted to identify a moderate association with the consumption of dairy products, use of 
milk formula and duration of breastfeeding (Figure 17). Interestingly, the latter conditioned not only 
the substitutive feeding but also the intake of milk derivatives in further life. Familial risk, 
comorbidities and natural/caesarean or premature delivery did not show a significant relationship 
with the serological status. Body mass and age formed a separated cluster that had a major impact 
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Figure 17. Bi-plot distribution of 
variables in relation to positivity for 
Abs against MAP, ZnT8 and PI 
peptides in T1D subjects. Circles 
indicate the variables relative to 
patients’ demographics, early-life 
diet and associated risk factors. 
Blue dots correspond to single 
samples for which all data relative 
to the analyzed variables were 
available (n=34). The presented 
principal components account for 









Following the investigations on anti-MAP seroreactivity in Italian youths, the question whether 
unrelated populations originating from biogeoraphically distinct environments may present similar 
Abs status was posed. In the present study, Polish T1D patients displayed an increased Abs 
prevalence against MAP and the homologous proinsulin peptides, however this result followed the 
serological pattern previously obtained in Sardinian children at a high risk for T1D rather than 
humoral responses observed in youths with T1D susceptibility from mainland Italy. Different 
immunogenicity of the selected peptides may be due to genetic predisposition towards specific 
antigens and cultural conditioning. Neonatal exposure to MAP may also play a significant role as 
adaptive immunity in early life is characterized by reduced allo-antigenic recognition, tolerogenic 
reactivity and poor responses to foreign antigens184.  
To better characterize the impact of MAP-derived antigens and their possible cross-reactivity 
with human homologs, MAP3865c133–141 and ZnT8186-194 peptide pair was selected for 
immunostimulation assays based on results previously observed in Italian youths; this choice was 
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and control groups as well as small number of included patients must be considered when evaluating 
further results. When evaluating humoral responses, the addition of each antigen to PBMCs isolated 
from the pilot cohort induced shifts in the production of some proinflammatory cytokines as observed 
in other experiments. Particularly high levels of IL-1β, especially in subjects bearing anti-MAP Abs, 
may indicate the activation of macrophages following to overproduction of Th1 cytokines185.  
Only slight increase of INFγ concentrations is in line with another report describing poor 
cytokine mRNA expression in Iranian T1D patients186. INFγ has been considered an important 
mediator of immune responses against mycobacterial infections and its secretion may be inhibited 
by other cytokines such as TGFβ and IL-10187-188. It is possible that, since IL-10 and TGF-β are 
already upregulated in patients with clinical T1D, cytokine balance may have been skewed towards 
impaired protection against MAP in antigen-stimulated cell cultures. By unknown mechanisms, MAP 
is able to evade proinflammatory Th1-like responses that during the subclinical phase of infection 
are lost and a Th2-like response, characterized by production of antibodies, predominates189. 
However, in T1D subjects positive for anti-MAP Abs, stimulation with MAP3865c133–141 caused a high 
production of INFγ compared to MAP-unresponsive patients and an inverse trend was registered for 
ZnT8186-194.  
 Similarly, the production of IL-12p40 was elevated in both patients and control subjects with 
higher values for either obese or T1D subjects negative for anti-MAP Abs. Experiments performed 
on monocyte-derived macrophages infected with MAP reported no up-regulation of IL-12p40 gene 
pointing again at an immune evasion strategy of the mycobacterium; at the same time, an increase 
in IL-12p40 production may be helpful in the suppression of T1D as demonstrated in NOD 
mice190-191. Likewise, TNFα is expressed at high levels in both in vitro differentiated Th1 and Th17 
cells promoting autoimmunity and acts as an important mediator in inflammatory disorders including 
obesity192-193. In the present study population, untreated PBMCs of both T1D and control subjects 
showed raised TNFα concentrations that further increased in obese patients upon stimulation with 
the homologous peptides, while levels in MAP3865c133–141-stimulated cells appeared reduced. Low 
TNFα production by T1D group may result from acquired antigen-specific tolerance194. In contrast, 
MAP-infected macrophages show raised expression of TNFα accompanied by the lack of IL-12 
induction and limited apoptosis136. 
 In the immunostimulation experiments, the effect of MAP/ZnT8 peptides on cell death leaded 
to highly increased early apoptosis of PBMCs. This phenomenon is widely discussed in the scientific 
literature due to contradictory results. Some indices suggest that through such a mechanism 
macrophages eliminate live mycobacteria or, on the other hand, bacteria adopt measures to 
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overcome host’s immune responses195. This way, exposure to high MAP loads caused the apoptosis 
of infected macrophages through dose-dependent pathways, while low MAP concentrations did not 
induce cell death in a manner that may parallel events occurring during natural infection196. By 
maintaining macrophages in life, MAP ensures itself more time for replication and hampers the 
presentation of bacterial antigens that decreases the risk to be detected by the immune system. 
However, pro-survival signaling identified in MAP infected tissue appears more pronounced during 
early Abs responses without the typical cell-mediated immunity associated with MAP clearance197. 
 The CD14+/CD16+ monocyte subset was selected for further evaluation as it has been linked 
to several conditions in autoimmune diabetes and demonstrated to promote the pathological picture 
in obesity198-199. Moreover, the increase of these monocytes was noted in tuberculosis and several 
bacterial sepsis200. Yet, expanded CD14+/CD16+ cells but not the classical monocytes showed 
reduced TNF expression following stimulation with LPS which probably evolved as a protective 
mechanism against excessive cytokine production201. In line with these observations, anti-MAP-
positive T1D patients displayed high CD14+/CD16+ coupled with low TNFα concentrations especially 
in PBMCs incubated with MAP3865c133–141. Conversely, stimulation with the homologous ZnT8186-194 
was associated to a pronounced percentage of CD3+ cells characterized by bigger differences 
between T1D and control subjects rather than in relation to anti-MAP seropositivity. Analysis on a 
more numerous group of patients with healthy subjects as reference controls would provide major 
details on the potential impact that MAP-derived antigens may exercise in T1D development. 
Finally, the presence of anti-MAP Abs identified in patients’ serum was analyzed in relation 
to possible links with clinical parameters, perinatal conditions and early-life diet. Interestingly, the 
results partially reflected associations found in Iranian CD patients whose Abs reactivity to the same 
MAP-derived antigens was paralleled by a high consumption of fast food meals but only partially by 
the intake of milk and pasteurization, while green tea and breastfeeding was inversely associated202. 
For the current cohort, information regarding dietary habits included only dairy products and nutrition 
in the first months after delivery. Complementary or exclusive feeding with infant formula leaded to 
a more frequent consumption of milk derivatives later in life which, however, was moderately 
correlated with anti-MAP seroreactivity. Similarly, breastfeeding showed only a partial relationship 
that might be dependent on cultural references based on the integration with milk formula. These 
results are supportive of the hypothesis seeing pasteurized dairy products as vehicles of viable MAP 
cells or their fragments acting as antigens cross-reactive with self-protein fragments. Further, low 
impact of familial risk and mode of delivery points at the importance of environmental agents in the 
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V. Detection of Abs against MAP in Sardinian LADA patients 
 
This chapter is based on the following study: 
Niegowska M et al. Increased seroreactivity to proinsulin and homologous mycobacterial peptides in 
latent autoimmune diabetes in adults. PLoS One. 2017 May 4;12(5):e0176584. 
 
The present study describes Abs responses to the selected MAP, ZnT8 and PI homologous 
peptides in Sardinian LADA patients with further evaluation based on age-related classification and 
disease phenotype performed in the attempt to investigate whether earlier results may reflect the 
hypothesis of common factors underlying T2D and LADA etiology203 and help in identifying the risk 




After a single-peptide analysis, no significant differences in responsiveness to the analyzed 
antigens were found between LADA subjects and HCs with the exception of MAP2404c70-85/PI46-61 
pair (Figure 18), for which Abs prevalence characterized by high statistical significance exceeded 
17% in LADA patients and 9% among HCs (p<0.0009 for MAP2404c and p<0.0004 for the 
homologous PI, Figure 19A). Fisher’s exact test performed based on the numbers of positive and 
negative subjects further confirmed the significant results when comparing LADA patients and HCs 
(p<0.028 for MAP2404c70-85 and p<0.039 for PI46-61). Moreover, a high degree of correlation (r2=0.68; 
Figure 19B) was detected between Abs titers recognizing the two homologs in either patients or HCs 
suggestive of cross-reactivity.  
Responses to the six remaining peptides were distributed evenly among LADA subjects at 
the level of 10.31-11.66%. HCs displayed somewhat lower Abs positivity towards both MAP-derived 
peptides homologous to ZnT8 accounting for 7.69%, whereas percentages of anti-ZnT8 Abs were 
similar to those observed in the patient group. Similarly, prevalence of Abs directed against 
MAP1,4αgbp157-173/PI64-80 epitope pair among HCs remained slightly below 10%. Analysis of 
separated groups defined by high and low GADA titers (LADA1 and LADA2, respectively) confirmed 
the above mentioned results with respect to HCs, however no differences in mean values or Abs 
prevalence were found between the two disease phenotypes (Figures 19C and 19D). In fact, 
MAP2404c70-85/PI46-61 homologs were recognized by 15.00-16.25% of patients in each LADA group 
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(p<0.0037), whereas immune reactivity towards the other selected peptides appeared leveled off at 
8.47-12.50% (Figure 18B). 
 
Figure 18. Prevalence of Abs against MAP, proinsulin and ZnT8 homologous epitopes in LADA patients and HCs. The 
histograms represent percentages of subjects with Abs positivity to selected epitopes upon single-antigen analysis; sera 
were tested in duplicate for their reactivity against plate-coated peptides. (A) Dark bars represent LADA patients; light grey 
bars correspond to HCs. (B) Abs prevalence among LADA 1 (dark bars) and LADA 2 (light grey bars) patient groups. 
Relative percentages and standard deviations are reported for each bar. 
Figure 19. Prevalence and correlation of Abs specific for MAP2404c70-85/PI46-61 peptide pair in LADA patients and HCs.  
(A) Distribution of Abs values for MAP2404c70-85 (M2) and PI46-61 (PI2) antigens. Horizontal bars specific for LADA and 
HCs groups correspond to means. AUC and p values (CI 95%) are indicated above the distributions. (B) Correlation 
between Abs recognizing MAP2404c70-85 and PI46-61 homologous epitopes in LADA subjects and HCs. Each dot represents 
Abs detected in one sample; in both graphics the dotted lines indicate positivity thresholds established for each assay 
based on the ROC analysis. (C) 
Distributions relative to Abs titers of M2 
and (D) PI2 in LADA1 and LADA2 
patients with HCs as reference; p values 
calculated by Kruskal-Wallis test as well 
as percentages of Abs prevalence in 
each group are reported above the 
distributions.  
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Data relative to other islet autoantibodies were available for 188 patients; among them 43 
individuals resulted positive to IA-2A, of which 12 (30.23%, Table 3) had anti-MAP Abs and those 
directed against MAP2404c70-85/PI46-61 epitopes were detected in 9 subjects (25.58%). IA-2A-
negative patients showed 18.71% of general anti-MAP Abs prevalence that decreased to 16.77% 
when only the statistically significant pair of homologs was considered. After division of patients in 
disease subtypes, we obtained 8 IA-2A-positive LADA1 and 35 LADA2 patients among which 3 and 
10 subjects, respectively, with anti-MAP/PI Abs. Patients without elevated IA-2A titers had Abs 
against MAP/PI antigens in 13 cases for LADA1 and 15 for LADA2 (19.70% and 18.99%, 
respectively). 
 
Table 3. Reactivity MAP, ZnT8 and PI antigens in relation to IA-2A titers. 
 
*Antigens for which statistically significant values were obtained. 
 
74 LADA1 and 114 LADA2 subjects with complete clinical data were selected from the study 
population and further classified in four age groups: 32-41, 42-51, 52-61 and ≥62 years, for which 
Abs prevalence was calculated either to all peptides together or to the homologous pair MAP2404c70-
85/PI46-61 separately (Table 4). Seroreactivity was evaluated between patients and HCs as well as in 
distinct LADA phenotypes with regard to age at onset and at the time of blood collection. The 
youngest and the oldest patients were both diagnosed with LADA1 at 32 and 77 years old, 
respectively. In all disease groups, the highest reactivity to at least one of the analyzed epitopes was 
registered in the youngest individuals, even though only slightly lower prevalence was observed after 
61 years for LADA2; the weakest responses corresponded to the 42-51 age range except for LADA1 
for which the lowest seroreactivity occurred in the oldest subjects. When Abs against only 
MAP2404c70-85/PI46-61 homologs was taken into account, the highest prevalence was assigned to the 
32-41 group for LADA1 and ≥61 year old patients for LADA2; for both phenotypes quite high positivity 
with significant values was maintained in the 52-61 group (p<0.0001). Independently from the 
analyzed peptides, HCs presented a progressive loss of Abs with age.  
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Clinical history regarding insulin-free period after LADA diagnosis was complete for 142 
patients. Most of them (n=127; 63.68% with LADA2 phenotype) required insulin therapy within 4 
consecutive years and only 23 subjects undergone insulin treatment within 12 months following 
LADA onset (69.57% with LADA2). Differences in anti-MAP positivity between periods of insulin 
independence reached 1% until 48 months when both LADA phenotypes were analyzed together 
(Table 4) with the exception of insulin treatment started after 13-24 months characterized by the 
highest seroreactivity; after splitting of patients according to LADA subtypes, LADA1 subjects 
showed Abs prevalence increasing with length of insulin-free periods from 14.28% to 25%, while 
opposite trends were observed for LADA2 decreasing from 18.75% to 10% of seropositive 
individuals. However, a few positive cases in each period do not permit to draw significant 
conclusions.  
 
Table 4. Seroreactivity to MAP, ZnT8 and PI epitopes in different age groups and during insulin independence period. 
Percentages of patients positive to the analyzed epitopes are reported along with the relative numbers of seroreactive 
subjects given in brackets. Mann-Whitney U test was employed to calculate statistical significance. 
 
* Statistically significant. a Samples collected at the time of LADA diagnosis. b Samples collected during a control medical 
visit following LADA onset. c Expressed in months. 
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Although sex-related analysis did not reveal associations with high titers of Abs against the 
selected peptides, the number of males and females varied among LADA phenotypes based on 
patients’ age at onset. Men accounted for 60% of LADA1 subjects between 32 and 51 years old, 
whereas proportions in older groups were close to 1:1. In contrast, individuals assigned as LADA2 
and aged 42-51 or older than 61 years at diagnosis were characterized by 1:2 male to female ratio. 
 
Discussion 
The study cohort selected from Sardinian population displayed increased prevalence of Abs 
targeting a portion belonging to a  MAP-derived putative regulator for proline utilization (MAP2404c) 
and its human PI homolog with high sequence identity corresponding to contiguous fragments of B 
chain and C-peptide. Responses to the same epitope pairs were even higher in Sardinian infants at 
risk for T1D and new-onset children from mainland Italy. In a similar fashion, increased seroreactivity 
to ZnT8 transmembrane regions and their homologous MAP peptides (MAP3865c) has been 
observed in either Sardinian or Italian cohorts at different disease stages149-150, 204-205. These results 
are in line with the ubiquitous presence of MAP in the environment and the frequency of exposure 
resulting in a straightforward transmission pathway to humans. Detection of Abs may indicate past 
contact with MAP following to consumption of contaminated food; most likely the intracellular form 
of MAP acquires enhanced virulence for humans after passage through bovine macrophages 
present in milk and cheese206. On the other hand, raised anti-MAP Abs titers have been found in 
individuals at continual interaction with infected animals such as veterinarians or livestock breeders; 
seropositivity among HCs and subjects at-risk for diabetes who do not develop clinical symptoms 
can be explained by exposure in early childhood to the extracellular phenotype of MAP that may 
confer natural immunity protective against mycobacterial infection145.  
Unlike T2D patients who do not display significant anti-MAP responses153, LADA2 was 
characterized by similar Abs titers as LADA1 subtype. This outcome confirms the hypothesis 
involving MAP in the pathogenesis of autoimmune diabetes and sustains distinct mechanisms 
underlying the development of LADA2 with prevailing autoimmune component despite etiological 
factors shared with T2D. Among genetic risk factors, single nucleotide polymorphisms (SNPs) in 
TCF7L2, resulting in increased expression of the transcriptional factor, have been linked to T2D and 
LADA phenotype with low GADA titers207-208, whereas other authors have not reported any 
association209-210. Interestingly, TCF7L2 down-regulation has been observed in MAP-infected bovine 
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monocyte-derived macrophages211. Data relative to TCF7L2-conferred risk were not available for the 
study cohort, however a future assessment based on the combination of these two factors in 
Sardinian population, considered its genetic homogeneity172, may provide additional elements to 
complete the present thesis.  
Age-related analysis showed major prevalence of anti-MAP positivity for all the eight peptides 
in the youngest group (32-41 years) of LADA patients assessed either regardless or depending on 
GADA titers. When only the significant MAP/PI epitope pair was envisaged, this trend switched to 
the group over 61 years old for LADA2, while remained unvaried for LADA1 and for the general study 
population, even though the latter presented high Abs titers also in older groups. It is plausible that 
anti-mycobacterial Abs remain detectable at high levels even after 20 years following LADA 
diagnosis in a similar way to GADA titers212, indicating a possible appearance of their peak values 
at a younger age. In the present study, responses to MAP antigens were not gender-associated, 
however Abs positivity in predisposed subjects, especially those assigned as LADA1, may suggest 
an increased risk for autoimmune thyroiditis. Comorbidity of both diseases has been already 
described and high GADA titers in males seem to be predisposing for thyroid autoimmunity115. 
Moreover, males aged 32-51 years at disease onset accounted for 60% in LADA1 subgroup 
reflecting findings observed in case of T1D that confirm male excess in populations with high 
incidence such as Sardinia15. Male to female 1:2 ratio among LADA2 subjects was similar to 
distributions described for T2D.  
Further assessment of patients’ reactivity to the selected peptides in correlation with time 
interval from LADA diagnosis to insulin dependence showed Abs prevalence relative to the 
significant MAP/PI epitope pair distributed homogeneously among subjects with insulin-free period 
from 18 months to 4 years (within the range 17-18%); the percentage was slightly higher among 
patients requiring insulin treatment between 13-24 months (23.53%) and much lower in those without 
therapy after 4 years from LADA onset (14.28%). Surprisingly, after separated analysis of the two 
disease phenotypes, the decreasing anti-MAP Abs positivity trend was maintained for LADA2 
subgroup and showed an inverted picture among LADA1 individuals. These results may suggest a 
possible association of MAP with a more severe disease course in LADA2 phenotype leading to a 
sooner need for insulin dosage, however a small number of patients assigned to each insulin-free 
period did not permit to obtain statistical significance. Moreover, no relation with GADA titers has 
been found in previous studies. A deeper insight should be dedicated to this question given the 
increased anti-MAP responses detected among IA-2A-positive subjects.  
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This work provides evidence of increased prevalence of antibodies directed against MAP 
epitope and its homolog derived from human proinsulin in LADA patients. Furthermore, it is in line 
with our previous findings highlighting elevated positivity to MAP in pediatric and adult populations. 
Further study is needed to address genetic predisposition in correlation with anti-MAP reactivity and 
the presence of non-islet organ-specific autoantibodies as a possible indication of comorbidities. Yet, 
information relative to risk factors in dietary habits may be useful in determining any correlation of 
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VI. Prevalence of anti-MAP Abs in Sardinian HT adults 
 
This chapter is based on the following study: 
Niegowska M et al. Antibodies against Proinsulin and Homologous MAP Epitopes Are Detectable in 
Hashimoto's Thyroiditis Sardinian Patients, an Additional Link of Association. PLoS One. 2015 Jul 
20;10(7):e0133497. 
 
 Similarly to T1D, HT is an organ-specific disease characterized by T-cell infiltration, 
cell-mediated immunity and production of autoantibodies that lead to dysfunction or destruction of 
the target organ. It is estimated that about 20% of T1D patients is positive to anti-thyroid Abs and, 
inversely, 2.3% of children with AITD have Abs against β-cells175, 213-214. While the scientific literature 
includes numerous studies describing levels of anti-thyroid Abs in T1D patients, only few papers 
evaluate the status of anti-islet autoimmunity in subjects affected by AITD, in particular related to 
specific epitopes. The current study, inspired by the above-mentioned findings along with the 
detection of seroreactivity against MAP/ZnT8 antigens observed also in subjects with autoimmune 
diabetes150, aimed at verifying the presence of anti-PI and homologous anti-MAP Abs in HT patients, 




 Among 177 HT patients, 20.34% (n=33) showed positivity to at least one of the four assessed 
peptides (Figure 20A). 48.5% of positive subjects had Abs against at least two peptides, 87.5% of 
which were positive to any of the homologous peptide pairs. One HT patient was reactive to all 
analyzed peptides. When single-peptide analyses of Abs reactivity were performed, 9 HT patients 
resulted positive to MAP1,4αgbp157-173 (5.08%) compared to only 0.57% of HCs (AUC=0.6, 
p<0.0003) (Figure 21A). The homologous PI64-80 peptide was recognized by 33 patients (18.64%) 
and 7.43% of HCs (AUC=0.6, p<0.002, Figure 21B). 
 Serum Ab reactivity to MAP2404c70-85 and its homolog PI46-61 was observed in 6 (3.39%) and 
7 (3.95%) HT patients, respectively, with no Ab against both peptides detected in HCs, however the 
differences were not significant. 
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 Considering positive cases, a higher immunoreactivity to both homologous peptide pairs was 
found among women, accounting for 90.48% for MAP1,4αgbp157-173, 96.15% for PI64-80, 100% for 
MAP2404c70-85 and 66,66% for PI46-61 (Figure 20B). Upon sex-based analysis of the study population, 
prevalence of positivity to MAP1,4αgbp157-173/PI64-80 and MAP2404c70-85 was markedly higher among 
females, while responses to PI46-61 were slightly higher in men.  
 
 
Figure 20. Prevalence of serum Ab positivity to MAP1,4αgbp157-173/PI64-80 and MAP2404c70-85/PI46-61 homologous epitopes 
in Sardinian HT patients and age/sex-matched HCs. HTf: HT females. HTm: HT males. HCf: HC females. HCm: HC males. 
 
 In women (n=152), Abs against MAP1,4αgbp157-173 were detected in 12.50% of HT subjects 
and in 2.75% of HCs (AUC=0.63, p<0.0002, Figure 21C). Positivity to its human homolog PI64-80 was 
observed in 16.42% of patients, compared to 6.42% of HCs (AUC=0.61, p<0.001, Figure 21D). Even 
though anti-MAP2404c70-85 Abs were identified in 9.21% of HT patients and in 4.59% of HCs, while 
1.32% of female patients and none of sex-matched HCs resulted positive to the homologous PI46-61, 
statistical significance was not attained for this peptide pair.  
 Males (n=25) displayed higher but not significant levels of Abs against the homologous 
MAP1,4αgbp157-173 and PI64-80 giving 8% and 4% of positive patients, respectively, compared to HCs 
among which no Abs were detected. Serum reactivity was not observed for MAP2404c70-85 either in 
HT patients or HCs, whereas 4% of male patients and none of the HC subjects resulted positive to 
the homologous PI46-61 peptide (AUC=0.7, p<0.003, Figure 21E).  
 Six patients had diseases of non-autoimmune origin complicating HT: one patient positive to 
the first peptide pair had hepatitis C; one out of three HT women with hypertension responded to 
MAP1,4αgbp157-173 and showed anti-PI64-80 reactivity slightly below the fixed positivity threshold; two 
patients with T2D did not result positive to any of the anti-MAP/PI Abs. Three HT patients had 
concomitant autoimmune diseases: one with allergic asthma did not show significant levels of Abs 
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against any of the studied peptides; one male 
patient with coeliac disease (16 years) 
responded to MAP1,4αgbp157-173/PI64-80 peptide 
pair and had Abs values close to the cut-off for 
MAP2404c70-85; one HT female with psoriasis (33 
years) was positive to Abs against PI46-61. 
 
Figure 21. Sex-related prevalence of Abs against 
MAP1,4αgbp157-173/PI64-80 and PI46-61 in Sardinian HT 
patients and HCs. Plasma was tested for immunoreactivity 
against plate-coated homologous MAP1,4αgbp157-173/PI64-80 and MAP2404c70-85/PI46-61 peptides. 
Statistical analyses were performed for all peptides separately in the context of entire study population (A, B), female (C, 
D) and male (E) HT subjects and HCs. The dotted lines indicate thresholds of positivity relative to each assay calculated 
by ROC analysis. The percentage of 
Abs-positive patients is reported on top of each distribution; horizontal bars correspond to means. AUC and p values (CI 
95%) are indicated in the top right corner. Only statistically significant data are reported. 
 
 Analyses of trends in age prevalence relative to Abs directed against any of the studied 
peptides revealed differences in positivity among HT patients’ age groups: <20 years (22.22%), 20-
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30 years (15.38%), 31-40 years (45.83%), 41-50 years (10,42%), 51-60 years (23.81%) and >60 
years (13.33%). Detailed data are presented in Table 5. 
 
 
Table 5. Age-related trends in prevalence of anti-MAP/PI Abs+ Sardinian HT patients. 
 
Values are reported as percentage of positive cases. PR: prevalence ratio calculated in relation to HCs; PR is not indicated 
when Abs+ cases were not found among HCs. Absence of Abs+ cases is marked by hyphens. 
 
 Anti-PI64-80 Abs were prevalent in each age group showing the highest positivity (48,67%) in 
patients 31 to 40 years comparing to 15.22% among HCs (AUC=0.65, p<0.03), followed by 21.43% 
of immunoreactivity among 51-60 year-old HT subjects (AUC=0.74, p<0.0002) and no responses 
registered for HCs. The homologous MAP1,4αgbp157-173 peptide was recognized by 4.16% 
(AUC=0.64, p<0.05) and 7.14% (AUC=0.73, p<0.0004) of patients from the respective age groups, 
while positive cases were not detected among HCs.  
 For the same age groups, 4.16% (AUC=0.64, p<0.04) and 4.76% (AUC=0.63, p<0.04) of HT 
patients displayed positivity to PI46-61. Abs directed against its homolog MAP2404c70-85 were not 
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observed among 31-40 year-old patients (AUC=0.67, p<0.01), but 2.38% of HT subjects 51 to 60 
years resulted reactive (AUC=0.69, p<0.004). All HCs were negative for this peptide pair.  
 In female patients, the highest prevalence of positivity to the studied peptides occurred for 
51-60 years group and accounted for 42.11%. In particular, a significant immunoreactivity to 
MAP1,4αgbp157-173/PI64-80 homologs was observed in 23.68% (AUC=0.68, p<0.016) and 21.05% 
(AUC=0.69, p<0.008) of HT women, respectively, compared to 4.76% of positivity to 
MAP1,4αgbp157-173 and no anti-PI64-80 Abs detected among female HCs. Highly significant results of 
Ab prevalence for the same peptide pair were obtained for 41-50 years group with 7.31% of female 
patients positive to MAP1,4αgbp157-173 (AUC=0.68, p<0.009) and 9.76% to the homologous PI64-80 
(AUC=0.7, p<0.003), whereas responses to these peptides were not detected in HC women.    
 Seropositivity among HT males was highest (33.33%) between 31 to 40 years of age due to 
the presence of anti-MAP1,4αgbp157-173 Abs (AUC=0.9, p<0.02). Positive cases were not detected 
among HC men for any of the analyzed peptides in all age groups.  
 Further analysis involved the association between the selected peptides and the titers of 
diagnostic HT autoantibodies. Even though 80% of HT patients reactive to MAP/PI peptides had 
anti-TPO Abs levels above positivity threshold, prevalence among anti-TPO negative subjects 
accounted for 60% compared to 27% among anti-TPO positive ones. A higher prevalence (36%) 
was observed for anti-TPO 100-1000UI/mL range and decreased to 15% for >1000UI/mL values. 
 All HT patients positive to MAP/PI peptides had anti-TG Abs above the 10UI/mL cut-off with 
32% prevalence and a homogeneous distribution up to 5000UI/ml. 
 67% of MAP/PI immunoreactive HT subjects had TSH levels below or above the normal 
range values (0.46-4.68µU/ml) with an overall prevalence of 29%. Prevalence relative to 
<0.46µU/ml TSH accounted for 20% and for 32% when values exceeded 4.68 µU/ml. Patients with 
normal TSH values showed 19% prevalence of anti-MAP/PI Abs positivity.  
 Only 7% of HT patients responding to MAP/PI peptides had FT3 levels exceeding the 
5.26pg/ml threshold, however the prevalence reached 33% compared to 21% for subjects with 
normal FT3 values.  
 FT4 levels fell outside the normal range of 0.77-2.19 ng/dl in 14% of MAP/PI-positive HT 
subjects, with 33% and 50% prevalence for values below and above the reference thresholds, 
respectively. Prevalence of MAP/PI reactivity among patients with normal FT4 values equaled 21%. 
 Anti-TPO Abs concentrations moderately correlated with both MAP peptides in MAP/PI 
positive HT subjects, however statistical significance was not attained. Upon sex-related analyses, 
males presented a high correlation with PI46-61 (0.89, p<0.042); the remaining peptides correlated 
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moderately or even highly for MAP1,4αgbp157-173, yet without significance. Moderate but not 
significant correlation with MAP epitopes was found among females.  
 Although age-related analysis did not produce significant results, a moderately high 
correlation of anti-TPO Abs with MAP1,4αgbp157-173/PI64-80 homologous peptides was detected in the 
31-40 year-old group. No correlation with anti-TG Abs concentrations and levels of TSH, FT3 and 
FT4 was found for any of the analyzed peptide pairs.  
Discussion  
 HT is the most frequent organ-specific autoimmune disorder complicating T1D by 
involvement of common immunological processes shared by different autoimmune diseases175. In 
Sardinian population, AITD is a prevailing autoimmune disease, while T1D is well known to have the 
second highest prevalence worldwide212. Previous outcomes showed a markedly significant 
association of MAP with T1D analyzed through detection of seroreactivity against identical MAP/PI 
homologous peptides as those used in the present study. Positivity to both peptides in HT subjects 
is identified in most cases within the same person providing another indication that homologous MAP 
and PI regions may be cross-recognized by human Abs. Even though comorbidity and familial 
aggregation of autoimmune diseases envision common genetic determinants, substantial co-
existence within siblings compared to incidence between successive generations highlights 
environmental impact215. In this study, 54.38% of patients with complete clinical data had HT history 
in family. This ratio reached 70% among HT subjects positive to any of the analyzed peptides, 
suggesting a possible transmission of MAP, MAP-derived peptides or anti-MAP Abs within family.  
 While women are 5-10 times more affected by HT216, there is no T1D sex-prevalence in 
childhood, although morbidity among men of European origin is more common in early adulthood217. 
The current results are partially consistent with these trends, accounting for almost 86% of women 
in the HT study population and showing a higher prevalence of anti-MAP and anti-PI Abs among 
adult females. 5% prevalence of GADA in HT non-diabetic patients was reported not to impair insulin 
action or secretion218. Prevalence to three out of four peptides analyzed in this study was up to 5%, 
however positivity to PI64-80 exceeding 18% of HT patients could increase the risk for adult-onset 
diabetes. A high prevalence of seropositivity to glutamic acid decarboxylase (GAD) has been 
documented in Japanese patients with AITD when compared to HCs and patients with thyroiditis of 
non-autoimmune origin, however the major contribution was attributed to Grave’s disease (GD), 
whereas HT patients presented only slight but not significant GADA prevalence219. As suggested, 
AITD patients with high GADA titers and positivity to multiple islet autoantibodies are at risk for the 
development of T1D. Similarly, no significant positivity for IAA and anti-insulin receptor Abs (AIRA) 
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has been reported in HT patients but high levels of both autoantibodies were typical for GD 
patients220. In contrast, anti-IAA were detected by other authors221-223, even though a further study 
describes high responses to GADA in non-diabetic HT patients with negative association to IAA224.   
 Interestingly, age-related analyses revealed a markedly higher prevalence of anti-MAP/PI 
Abs in HT patients 31 to 40 years old indicating a possible association with latent autoimmune 
diabetes in adults (LADA), even though IAA tend to be undetectable in late-onset T1D. This fact 
points at a putative involvement of MAP as an environmental agent contributing to the development 
of autoimmunity and permits to hypothesize a cross-reaction between the homologous peptides. In 
HT females, this trend was switched to the period of 51-60 years old, although a significant 
prevalence was already visible in 41-50 age group. This trend is typical for age-related incidence of 
T2D that lacks the association with MAP153; similarly, two HT patients with concomitant T2D included 
in the present study resulted negative to both MAP/PI peptide pairs. High prevalence of anti-MAP 
Abs in older groups of Irish cattle affected by Johne’s disease225 may indicate a similar time-
depending natural scenario of immune responses in MAP-positive subjects. Finally, the onset of 
autoimmune diseases in males is supposed to occur earlier compared to females and is 
characterized by acute inflammation and the appearance of aAbs226. In the enrolled study population, 
mean anti-MAP/PI Abs titers among positive patients were higher in men. 
 Regardless a lower prevalence of anti-MAP/PI Abs in children and youth (<20 years), two HT 
patients had very high Abs values for three peptides. The same Abs are demonstrated to appear 
before the classical anti-islet autoantibodies in Sardinian children at onset of T1D, therefore, may 
suggest a developing β-cell autoimmunity. The presence of anti-MAP/PI Abs in two out of three HT 
patients with concomitant autoimmune diseases may point at prediction of multiple autoimmune 
syndrome (MAS), however such an association should be investigated in a wider group. Since 
dermatological conditions have an important place in MAS, it would be of particular relevance for 
patients with psoriasis, the most frequent autoimmune disease affecting Sardinian men. 
 The analysis of clinical data showed reactivity to MAP/PI epitopes among HT patients to be 
associated with the presence of anti-TG Abs and high TSH levels. Although FT3 and FT4 presented 
a high prevalence outside the reference range, only a few cases fell within this group. Anti-TPO Abs 
were detected in 80% of MAP/PI-positive patients and revealed a moderate correlation with 
concentrations of anti-MAP Abs; a high prevalence of Abs against the homologous peptides among 
anti-TPO-negative HT subjects requires evaluation in a wider number of patients. For this thyroid 
biomarker, correlation with proinsulin became even stronger when analyzed separately in males. 
Interestingly, low anti-TPO Abs concentrations corresponded to higher values obtained for Abs 
directed against MAP peptides; this combination may indicate a possible protective link against 
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raising anti-TPO Abs titers, especially between 31 and 40 years, but could be confirmed following to 
further investigation of Abs dynamics in the analyzed patients. Conversely, Abs against proinsulin 
correlated positively with increasing anti-TPO Abs concentrations in men suggesting a probable risk 




 A more frequent occurrence of Abs against homologous MAP-derived and human antigens 
in T1D patients compared to healthy population provides indices for a strong environmental 
component in the development of autoimmunity. There are no proofs whether MAP infects 
predisposed hosts as a causative agent or takes advantage of favourable conditions that arise with 
the physiological imbalance leading to the loss immune tolerance. An additional link of association 
given by a high prevalence of anti-MAP Abs in Hashimoto’s thyroiditis suggests at least partially 
common mechanisms governing the onset of several autoimmune diseases that tent to appear in 
concomitance. The increasing prevalence of T1D in developed countries during last century goes 
hand in hand with the introduction of intensive breeding which facilitates intraherd MAP infections 
and contamination of animal products. Indeed, detection of viable MAP in retail meat, fresh milk and 
derivatives including infant formula hints at a straightforward transmission route. While human 
exposure to MAP is potentially easy and frequent since early life, peculiar characteristics of the 
mycobacterium such as extremely low growth, asymptomatic latency periods and tropism to 
intestinal macrophages make difficult the investigation. For a deeper understanding of the interplay 
between genetic susceptibility to MAP infections and effective presence of mycobacterial cells in 
T1D population, NOD2/CARD15 mutations should be evaluated in relation to anti-MAP 
seropositivity, detection of specific IS900 gene and isolation of viable MAP from patients. Further 
steps should also focus on in depth assessment of cell-mediated immunity with regard to disease 
phase and particular attention on MAP-correlated shifts in the self-tolerance equilibrium. These 
results will not definitively solve the question in a similar manner to Crohn’s disease that despite a 
strong evidence obtained over decades of research lacks the decisive proof, but certainly will add 
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 In the framework of the TRIGR study, 23 Sardinian children at risk of T1D (i.e. with a first-
degree relative affected by T1D; mean age 2.8±2.7 years) attending the Department of Diabetes, 
St. Michele Hospital of Cagliari, Italy were enrolled in the study and followed in time in order to 
identify a correlation between the presence of Abs and the onset of diabetes. The first blood samples 
were collected at birth with further annual collections up to 10 years, giving in total 139 samples over 
the period of 2002-2012. In addition, all at-risk subjects were analyzed for the presence of ICA, 
GADA, IA-2A and IAA (Table 6). Reference control samples of age-matched healthy volunteers 
(n=22, mean age 4.3±2.1 years) were provided by the Tor Vergata University Hospital of Rome.  
 
Table 6. Demographic characteristics and pattern of islet autoantibodies in T1D at-risk subjects. 
ID 
Age at first blood collection 
(months) 
Age at detection of islet Abs 
(months) 
ICA IAA GADA IA2A 
2 4 - - - - - 
3 0 - - - - - 
4 3 - - - - - 
5 3 17 + + + + 
6 0 - - - - - 
8 0 - - - - - 
9 6 48 + - - - 
10 3 97 + - - - 
12 24 48 + + - + 
14 11 18 + + + + 
16 24 - - - - - 
20 24 85 + - - - 
22 18 - - - - - 
24 9 - - - - - 
26 0 - - - - - 
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Age at first blood collection 
(months) 
Age at detection of islet Abs 
(months) 
ICA IAA GADA IA2A 
27 12 - - - - - 
32 24 - - - - - 
33 12 - - - - - 
34 0 - - - - - 
38 0 - - - - - 
39 0 - - - - - 
40 0 - - - - - 
43 0 - - - - - 
0: blood collected at birth 
 54 children and youth (n=27 males and n=27 females, mean age 9.42±3.84 years) at risk for 
T1D verified by the presence of disease familiarity and/or high risk HLA genotype, and reference 
control samples of age-matched healthy volunteers (n=42, mean age 6.94±3.58 years) without 
known history of autoimmune disorders or recent inflammatory episodes were enrolled in the present 
study following to periodical visits at the Tor Vergata University Hospital of Rome. Diagnosis of T1D 
onset was performed upon analyses for the presence of classical islet autoantibodies (ZnT8A, 
GADA, IA-2A and IAA) and levels of glycated haemoglobin according to the American Diabetes 
Association criteria227. For 27 patients, further time-point collections were performed, giving in total 
105 samples. Detailed patients data are provided in Table 7. 
 From this dataset, 32 subjects at risk for T1D (n=19 males and n=13 females, mean age 
8.90±3.52 years) and age-matched healthy volunteers (n=42, mean age 6.90±3.55 years) were 
selected in blind for the evaluation of seroreactivity against L5P. 
  
Table 7. Demographic and clinical characteristics of Italian T1D at-risk subjects.  
ID Agea Genderb HLA genotype Risk factor ZnT8c    IAAd   GADAe  IA2Af  
R01 12.65 M DQ2 (DQA1*0201-DQB1*0202) + DQ8 coeliac disease familiarity (brother) 0.00 0.1 0.25 0.11 
R02 9.22 F DQ2 (DQA1*0201-DQB1*02)  coeliac disease 77.99 0.00 1.13 0.00 
R03 4.08 F DQ2 (DQA1*0201-DQB1*02)  coeliac disease 0.00 0.51 4.10 0.90 
R04 5.61 M DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 45.50 - - - 
R05 18.89 M DQ2 (DQA1*0201-DQB1*0202) occasional hyperglycemia 30.00 0.00 0.00 - 
R06 15.18 F DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 3.00 0.3 0.47 0.23 
R07 4.94 F DR4 + DQ8 T1D familiarity (brother) 0.00 1.52 22.00 13.80 
R08 8.61 F DQ2 (DQA1*0201-DQB1*02)  T1D familiarity (brother) 56.80 - - - 
R09 4.91 M DQ2 (DQA1*0201-DQB1*02)  T1D familiarity (brother) 69.86 - - - 
R10 4.76 F DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 0.00 0.03 0.16 0.27 
R11 9.71 F - coeliac disease 0.00 0.1 0.09 1.56 
R12 8.15 M low risk T1D familiarity (brother) 39.40 0.4 0.25 0.44 
R13 5.31 M - coeliac disease 0.00 - - - 
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R14 5.24 M DQ2 (DQA1*0501-DQB1*0201) + DQ8 coeliac disease, autoimmune thyroiditis 39.99 5.98 54.70 0.32 
R15 1.92 M - suspected coeliac disease 14.00 0.1 0.01 0.03 
R16 7.16 F DR3 
occasional hyperglycemia,  
impaired glucose tolerance 
50.30 0.00 0.00 1.00 
R18 7.03 M DQ8 (DQB1*0302) T1D familiarity (brother) 0.00 - - - 
R19 13.16 F - coeliac disease, occasional hyperglycemia 0.00 - - - 
R20 8.33 M - coeliac disease 92.33 2.80 0.31 0.11 
R21 6.50 M DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 14.22 0.02 0.1 0.21 
R22 7.97 M DQ2 (DQA1*05-DQB1*02) 
coeliac disease, hyperthyrotropinemia,  
occasional hyperglycemia 
46.44 - 0,00 1.64 
R23 12.87 M DQ2 (DQA1*05-DQB1*02) coeliac disease 0.00 0.04 1.00 0.91 
R24 5.74 M DQ2 (DQA1*0201-DQB1*0202) coeliac disease, occasional hyperglycemia 56.16 0.02 1.22 1.00 
R25 8.28 F DQ2 (DQA1*0201-DQB1*0202) coeliac disease, autoimmune thyroiditis 93.48 - - - 
R26 6.32 F DQ2 autoimmune thyroiditis 63.45 - 4.57 - 
R27 7.18 M DR3 + DR4 + DQ2 (DQA1*0501-DQB1*0201/030503) T1D familiarity (brother) 74.30 0.52 1.16 0.10 
R29 14.65 F DQ2 (DQA1*0501-DQB1*0201) 
coeliac disease, vitiligo and  
autoimmune thyroiditis familiarity 
93.54 - - - 
R30 - F - T1D familiarity (brother) 30.00 - - - 
R31 12.92 M low risk T1D familiarity (brother) 47.62 0.02 0.25 0.53 
R32 8.03 F DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 8.00 0.09 4.93 0.23 
R33 15.12 M DR3 + DQ2 (DQA1*0501-DQB1*0201) T1D familiarity (brother) 22.36 - - - 
R34 5.09 F DQ2 (DQA1*0501-DQB1*0201) + DQ8 coeliac disease 33.81 8.66 33.77 13.51 
R35 8.12 F DQ2 (DQA1*05- DQB1*02) + DR3 + DR4 coeliac disease 0.00 1.10 39.10 7.00 
R36 3.97 M DQ8 T1D familiarity (brother) 30.00 - - - 
R37 12.11 M low risk T1D familiarity (brother) 0.00 0.00 0.00 0.00 
R38 7.83 F DQ2 (DQA1*0201-DQB1*0202) occasional hyperglycemia 63.36 0.00 0.00 0.00 
R40 11.83 F DQ2 (DQA1*0501/0201-DQB1*0202/0201) T1D familiarity (brother) 71.39 9.13 18.90 19.05 
R41 17.87 M - coeliac disease 30.00 - - - 
R43 10.40 M DQ8 (DQA1*0201-DQB1*0302) T1D familiarity (brother) - 0.00 0.00 0.00 
R45 14.17 F low risk occasional hyperglycemia 30.00 0.00 2.00 0.80 
R46 13.48 M - 
occasional hyperglycemia, obesity, 
T2D familiarity 
34.00 0.00 0.00 0.88 
R47 4.82 F DR7/DR4 + DQ8 (DQA1*0501-DQB1*030503) T1D familiarity (brother) 86.14 0.00 0.00 0.00 
R48 11.86 F DQ2 T1D familiarity (brother) 30.00 0.00 1132.00 0.00 
R49 11.00 F DQ2 (DQA1*0201-DQB1*02) coeliac disease, impaired glucose tolerance 0.00 0.00 0.00 0.00 
R50 14.15 M DQ8 T1D familiarity (brother) 0.00 0.00 0.00 0.00 
R52 9.12 M DQ2/DQ8 T1D familiarity (brother) 1532.05 0.90 0.33 1.00 
R53 10.02 F DQ2 (DQA1*05-DQB1*02) + DQ8 (DQB1*0302) TAG, occasional hyperglycemia 41.00 0.00 0.00 0.00 
R54 14.06 F DQ2 
T1D familiarity (father), coeliac and  
Grave’s disease familiarity (sister) 
150.75 1.82 3.12 1.70 
R55 11.41 F DQ2/DQ8 T1D familiarity (brother) 0.00 0.20 0.52 1.20 
R56 9.84 M DQ8 coeliac disease 0.00 9.13 3.46 0.16 
R57 9.99 M DQ2 occasional hyperglycemia 30.50 0.14 23.02 4.73 
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R58 7.36 F DQ2 T1D familiarity (brother) 0.00 0.00 0.29 0.18 
R59 13.64 M DQ2 (DQA1*05-DQB1*02) + DQ8 (DQB1*0302) T1D familiarity (brother) - 0.00 0.00 0.00 
R60 5.75 F DQ2 (DQA1*05-DQB1*02) + DQ8 (DQB1*0302) T1D familiarity (brother) - 0.00 0.00 0.00 
a Age at blood collection. b F=females, M=males. c Positive when >30U/mL. d Positive when >0.4U/mL. e Positive when 
>0.9U/mL. f Positive when >0.75U/mL. Positive Abs values are shown in bold. Hyphens indicate no measurements 
performed. ID of subjects who progressed to T1D are highlighted by bold characters; subjects with a high T1D risk 
conferred by the classical Abs status developed upon follow-up analyses are marked by italics. Age and Abs levels are 
representative for the initial blood collection when multiple time-point samples were available. 
 
 75 Polish children and youth at onset or with established T1D (n=48 females and n=27 males, 
mean age 13.01±3.52) were enrolled at the Department of Diabetology and Endocrinology of the 
Childrens’ Memorial Health Institute in Warsaw, Poland. The diagnosis was defined based on the 
circulating ICA, GADA and IA-2A, C-peptide concentrations and HbA1c levels. All T1D patients were 
under insulin pump or pen therapy at the moment of blood collection. Due to the poor availability of 
healthy subjects, 26 patients with obesity (n=16 females and n=10 males, mean age 12.54±2.99, 
mean BMI=27.35±4.53) but not affected by autoimmune disorders and free from any therapy were 
recruited at the same hospital unit as reference controls. The levels of inflammation were measured 
through CRP tests. All participants or their legal tutors the interview including information on the 
familial risk for autoimmunity, consumption of dairy products and infant milk formula, breastfeeding 
and comorbidity.  
 223 LADA patients (n=104 men and n=119 women, mean age 55.22±10.71 years) and 182 
age-matched healthy blood donors (n=102 males and n= 80 females, mean age 48.13±10.35 years) 
attending the Transfusion Medicine Department, University Hospital of Sassari, were enrolled in the 
present study. LADA patients have been referred as a part of a multicentric study, from five Diabetic 
Units of the island of Sardinia, Italy. The clinical features, autoimmune markers, and progression 
toward insulin dependence in these patients have been described in detail previously48. Any history 
of autoimmune or inflammatory disorders preceding blood collection from HCs was unknown. 
Diagnosis of LADA was performed upon analyses for the presence of circulating classical islet 
autoantibodies (GADA and IA-2A), age at onset and period of insulin independence according to the 
Immunology of Diabetes Society criteria. All patients were free from insulin therapy at the moment 
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 177 HT subjects (n=25 males, n=152 females; mean age 44.94±15.65 years) attending the 
Department of Endocrinology, University Hospital of Sassari, and 175 age/sex-matched healthy 
controls (n=66 males, n=109 females; mean age 42.18±13.23 years) were enrolled in this study. 
HCs were blood donors with no clinical evidence of T1D or other autoimmune diseases. The patients 
were diagnosed based on the presence of TPO and anti-TG Abs, as well as levels TSH, FT3 and 
FT4.  
 Venous blood samples were collected in EDTA-coated tubes after obtaining written informed 
consent for all study participants. A parent or a caretaker signed the participation consent for 
underage subjects. The study protocols were approved by the University of Sassari and respective 
enrollment centers in accordance with the Declaration of Helsinki. All methods were performed in 
accordance with institutional and governmental guidelines and regulations. 
 
T1D-related autoantibodies and clinical testing 
  
 Levels of Abs specific to the ZnT8 C-terminal region (268–369, 325R or 325W) were 
determined in the sera by protein A-radioimmunoprecipitation assays according to the protocol of 
Lampasona et al.228. Abs positivity threshold was set at the 99th percentile of 100 HCs obtaining the 
cut-off value exceeding 30U/ml. Inter-assay coefficient of variation (CV) accounted for 14%, whereas 
an intra-assay CV equaled 11%. 
 Abs to insulin, GAD65, and IA-2 were measured by radioligand assays using commercial kits 
(CentAK® IAA RT, CentAK® anti-GAD65, and CentAK® anti-IA2, Medipan, Germany) according to 
the manufacturer's instructions. Values are expressed in arbitrary units with the respective Abs 
thresholds of >0.4, >0.9 and >0.75 U/ml. Positivity to ICA was determined in a binary classification. 
 GADA titers were used to classify LADA patients in two groups based on a threshold 
established as previously reported229, defined as LADA1 for subjects with high GADA values and 
LADA2 subtype for individuals with low GADA levels. 
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 Epitopes derived from MAP proteins and their homologous human antigens used to assess 
humoral responses in the sera of patients with autoimmune diseases and HCs, as well as two 
peptides derived from Helicobacter pylori used as negative controls (Table 8) were synthesized at 
>90% purity (LifeTein, USA) assessed by HPLC. After reconstitution to 10mM concentration in sterile 
DMSO, the peptides were stored at -20°C in single-use aliquots for further assays. Specificity of the 
peptides has been tested previously through competitive inhibition assay149. 
 Synthetic L5P prepared as previously described183 was kindly provided by Frank Biet (INRA 
Centre de Tours, Nouzilly, France). Due to its hydrophobic nature, the peptide was reconstituted in 
methanol to obtain 1mg/ml stock solution, incubated for 2 hours with occasional gentle mixing to 
improve the solubilization and stored at -20°C in single-use aliquots protected from evaporation.  
 
Table 8. List of peptide antigens with respective amino acid sequences, percentage of sequence identity, source organism 
and confirmed or putative function.  
 
Homologous peptide pairs are evidenced by grey background. Homology between H. pylori and ZnT8 antigens is indicated 
by lateral bars. Alignment identity includes fully conserved residues and those with strongly similar properties. DF: 
D-phenylalanine. NMe: N-methylated. AOMe: O-methylated alanine. 
 
Detection of Abs directed against peptide antigens 
 
 Indirect ELISAs to detect Abs specific for the peptide antigens were performed on serum 
samples separated from whole blood by sedimentation or density gradient method and stored at 
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-20°C. For each assay, Nunc MaxiSorpTM flat-bottom 96-well plates (ThermoFisher Scientific, USA) 
were coated with 50μl of 10μg/ml peptide solutions in carbonate-bicarbonate buffer and incubated 
at 4°C overnight according to the in-house developed protocol. The solution was then eliminated 
and non specific binding sites were blocked for 1 hour with 5% skim milk in PBS-T. The plates were 
washed twice with 200μl of PBS-T for the subsequent addition of 100μl serum diluted 1:100 in PBS-
T into each well and incubation at room temperature for 2 hours. After washing with 200μl of PBS-T 
five times, the plates were incubated for 1 hour with 100μl of anti-human IgG whole molecule 
antibody conjugated to alkaline phosphatase (Sigma-Aldrich, USA). The wells were washed five 
times with 200μl of PBS-T for further addition of 200μl SigmafastTM p-Nitrophenyl phosphate 
substrate (Sigma-Aldrich, USA) in order to enhance colorimetric reaction with the enzyme. OD 
values were read within 10-15 minutes at 405nm on SpectraMax Plus 348 microplate reader 
(Molecular Devices, USA). To subtract background noise, blank assays were performed following 
the same procedure without including serum sample.  
 The obtained data were expressed as the mean of three separated tests and normalized to 
a strongly positive control serum included in all assays with Abs reactivity set at 1.0 AU/ml arbitrary 
units. Optimal cut-off values to discriminate between positive and negative samples were identified 
based on the ROC curves with specificity set at ≥88.46% for the Polish cohort and at ≥90% for the 
other study populations. 
 
In vitro stimulation of PBMCs with MAP3865c133–141 and ZnT8186-194 peptides 
 
 PBMCs were isolated from whole blood within 6h after collection through density gradient 
separation method and diluted with RPMI with 5% of heat inactivated filter-sterilized human serum 
in order to obtain an average concentration of 1.5x106 cells/ml. Cell viability was assessed through 
trypan blue exclusion tests on Luna II cell counter (ThermoFisher Scientific, USA). 500μl of cell 
suspension were incubated at 37°C 5% CO2 in presence of MAP3865c133–141 or ZnT8186-194 peptide 
with co-stimulatory molecules CD28/CD49d (BD Biosciences, USA). PHA was used as a highly 
stimulating standard. Incubation time was dependent on further analysis (Table 9). The culture 
supernatant was collected and stored at −20°C until cytokine analysis. The cells were treated 
immediately according to protocols for cell surface phenotype expression.  
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Table 9. PBMC culture conditions and control setup for immunostimulation. 
Negative control (K-) Positive control MAP3865c133–141 (P1)  ZnT8186-194 (P2)  Incubation time Analysis 
cells only 1μl PHA 
7.5μl P1 + 
2.5μl CD28/49d 









Volumes for 500μl of cell suspension if not specified otherwise. Cell cultures were performed on 24-well plates. 
Detection of cytokine levels  
 
Cytokine concentrations in PBMC cell culture supernatants were estimated following 18h (IL-
1B and TNFα) or 72h (IL-12p40 and INFγ) of stimulation by means of commercially available ELISA 
kits (OptEIAtm Set, BD Biosciences, USA). Each sample was diluted prior to the test according to 
producer's specifications and the final results were obtained by appropriate multiplication in the 
following ranges: from 3.9 to 250pg/ml for IL-1B, from 4.7 to 300pg/ml for INFγ and from 7.8 to 
500 pg/ml for TNFα and IL-12p40. The protein level in the diluted sample was calculated from a 
reference curve generated for a respective assay by using reference standards containing known 
concentrations of appropriate protein.  
 
Flow cytometry analysis of cell populations and apoptosis  
 
Cells were collected from culture plates and centrifuged at 300 x g for 5 minutes at 4°C. The 
obtained cell pellet was then resuspended in 1ml of FBS stain buffer (BD Pharmingen, USA) and 
incubated for 30 minuets at 4°C. After repeating the centrifugation and discarding the supernatant, 
cells were resuspended in 100μl of PBS and transferred to polystyrene vials containing 7μl of mouse 
anti-human monoclonal Abs conjugated to fluorescence-based indicators specific for cell surface 
receptors expressed on monocytes or lymphocytes (Table 10). Following to incubation for 20 
minutes at 4°C in dark conditions, 1ml of PBS was added to each sample and the vials were 
centrifuged as previously. To evaluate the apoptosis, cells were subsequently labeled with 
annexin V and 7-AAD using a commercially available apoptosis detection kit (Beckman Coulter, 
USA). Finally, 2-3 drops of PBS were added to cellular sediment destinated for cell population 
analysis upon removal of the supernatant. 
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FACSCanto II (Becton Dickinson, USA) was employed for flow cytometric acquisition on 
30000 events and the obtained data were analyzed using FlowJo software (version 7.6.1, Tree Star, 
USA). The results are reported as a percentage of cells showing expression of the studied receptors. 
 
Table 10. Cell-specific receptors and respective fluorescence-based indicators. 








CD3 PE 7.0 lymphocytes 
Statistical analysis 
 
Statistical significance of the data was determined through the unpaired student’s t-test or 
the Mann-Whitney U test (95% CI, two-tailed) for not normally distributed values using Graphpad 
Prism software (version 6.02, GraphPad Software Inc., USA). Fisher’s exact test was employed to 
establish p-values when percentages of positive and negative subjects were compared between 
patients and HCs. Pairwise correlation analyses were performed in order to evaluate the reactivity 
against homologous peptides. 
For LADA, variances of separated groups of LADA1 and LADA2 patients along with HCs 
were compared employing one-way ANOVA on ranks. 
Relationship between variables correlated with positivity to L5P and homologous peptide 
pairs was assessed through principal component analysis employing XLSTAT software (version 
2017, Addinsoft, France). The variable relative to HLA-inferred genetic susceptibility was classified 
in three groups according to low-, moderate- and high-risk T1D haplotype. Milk consumption was 
evaluated based on low/absent, moderate and high frequency. The cut-off for variable loadings 
describing the degree of correlation between variables and principal components was arbitrarily set 
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